Different types of algal-synthesized NPs and its antibacterial activity.
\\n\\n
Released this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\\n\\nWe wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
Note: Edited in March 2021
\\n"}]',published:!0,mainMedia:null},components:[{type:"htmlEditorComponent",content:'IntechOpen is proud to announce that 191 of our authors have made the Clarivate™ Highly Cited Researchers List for 2020, ranking them among the top 1% most-cited.
\n\nThroughout the years, the list has named a total of 261 IntechOpen authors as Highly Cited. Of those researchers, 69 have been featured on the list multiple times.
\n\n\n\nReleased this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\n\nWe wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
Note: Edited in March 2021
\n'}],latestNews:[{slug:"intechopen-signs-new-contract-with-cepiec-china-for-distribution-of-open-access-books-20210319",title:"IntechOpen Signs New Contract with CEPIEC, China for Distribution of Open Access Books"},{slug:"150-million-downloads-and-counting-20210316",title:"150 Million Downloads and Counting"},{slug:"intechopen-secures-indefinite-content-preservation-with-clockss-20210309",title:"IntechOpen Secures Indefinite Content Preservation with CLOCKSS"},{slug:"intechopen-expands-to-all-global-amazon-channels-with-full-catalog-of-books-20210308",title:"IntechOpen Expands to All Global Amazon Channels with Full Catalog of Books"},{slug:"stanford-university-identifies-top-2-scientists-over-1-000-are-intechopen-authors-and-editors-20210122",title:"Stanford University Identifies Top 2% Scientists, Over 1,000 are IntechOpen Authors and Editors"},{slug:"intechopen-authors-included-in-the-highly-cited-researchers-list-for-2020-20210121",title:"IntechOpen Authors Included in the Highly Cited Researchers List for 2020"},{slug:"intechopen-maintains-position-as-the-world-s-largest-oa-book-publisher-20201218",title:"IntechOpen Maintains Position as the World’s Largest OA Book Publisher"},{slug:"all-intechopen-books-available-on-perlego-20201215",title:"All IntechOpen Books Available on Perlego"}]},book:{item:{type:"book",id:"5469",leadTitle:null,fullTitle:"Canine Medicine - Recent Topics and Advanced Research",title:"Canine Medicine",subtitle:"Recent Topics and Advanced Research",reviewType:"peer-reviewed",abstract:"There is a possibility that during a pet's lifetime, medication may be recommended to treat medical conditions or problems. \nThis book Canine Medicine - Recent Topics and Advanced Research provides the knowledge in diagnosis and treatment of some important diseases and problems that the canines face.\nI believe that this book offers broader perspective to the readers in the recent advances in canine medicine, starting from recent topics to application in clinical diagnosis and therapeutics for practitioners and veterinarians.\nThe main purpose of the book is to point out the interest of some important topics of canine medicine and the progress in this field and to clear its importance in veterinary medicine.",isbn:"978-953-51-2832-8",printIsbn:"978-953-51-2831-1",pdfIsbn:"978-953-51-7329-8",doi:"10.5772/63036",price:119,priceEur:129,priceUsd:155,slug:"canine-medicine-recent-topics-and-advanced-research",numberOfPages:214,isOpenForSubmission:!1,isInWos:1,hash:"a7e798d88413dd09f8a4af2b2e325b82",bookSignature:"Hussein Abdelhay Elsayed Kaoud",publishedDate:"December 21st 2016",coverURL:"https://cdn.intechopen.com/books/images_new/5469.jpg",numberOfDownloads:16768,numberOfWosCitations:2,numberOfCrossrefCitations:1,numberOfDimensionsCitations:3,hasAltmetrics:1,numberOfTotalCitations:6,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"April 20th 2016",dateEndSecondStepPublish:"May 11th 2016",dateEndThirdStepPublish:"August 15th 2016",dateEndFourthStepPublish:"November 13th 2016",dateEndFifthStepPublish:"December 13th 2016",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,editors:[{id:"265070",title:"Dr.",name:"Hussein Abdelhay",middleName:null,surname:"Essayed Kaoud",slug:"hussein-abdelhay-essayed-kaoud",fullName:"Hussein Abdelhay Essayed Kaoud",profilePictureURL:"https://mts.intechopen.com/storage/users/265070/images/system/265070.png",biography:"Dr. Hussein Kaoud was the Chairman of the Department of Preventive Medicine at Cairo University. He has given lectures in Molecular Epidemiology and Biotechnology at different universities and has been a member of many International Publishing Houses, Reviewer, and Editor for indexed journals. Currently, he works as Full Professor of Preventive Medicine at Cairo University, Egypt. His research interest is focused on Molecular Biology and Advanced Technology of Basic Life Sciences after he had his Ph.D. and D.Sc. He has published more than 300 publications. Dr. Hussein Kaoud has several international books, one international award (USA), 10 Cairo university International Publication awards and the Appreciation Award in Advanced Technological Sciences, from Cairo University. He supervised, examined and discussed many medical dissertations.",institutionString:"Cairo University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"4",totalChapterViews:"0",totalEditedBooks:"3",institution:{name:"Cairo University",institutionURL:null,country:{name:"Egypt"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"299",title:"Cynology",slug:"cynology"}],chapters:[{id:"52760",title:"Canine Parvovirus Type 2",doi:"10.5772/65801",slug:"canine-parvovirus-type-2",totalDownloads:2040,totalCrossrefCites:1,totalDimensionsCites:1,signatures:"Chao-Nan Lin and Shu-Yun Chiang",downloadPdfUrl:"/chapter/pdf-download/52760",previewPdfUrl:"/chapter/pdf-preview/52760",authors:[{id:"190874",title:"Associate Prof.",name:"Chao-Nan",surname:"Lin",slug:"chao-nan-lin",fullName:"Chao-Nan Lin"},{id:"194988",title:"Dr.",name:"Shu-Yun",surname:"Chiang",slug:"shu-yun-chiang",fullName:"Shu-Yun Chiang"}],corrections:null},{id:"52967",title:"Canine Visceral Leishmaniasis in Brazil",doi:"10.5772/65956",slug:"canine-visceral-leishmaniasis-in-brazil",totalDownloads:1464,totalCrossrefCites:0,totalDimensionsCites:1,signatures:"Marcia Almeida de Melo, Raizza Barros Sousa Silva, Laysa Freire\nFranco e Silva, Beatriz Maria de Almeida Braz, Jaqueline Maria dos\nSantos, Saul José Semião Santos and Paulo Paes de Andrade",downloadPdfUrl:"/chapter/pdf-download/52967",previewPdfUrl:"/chapter/pdf-preview/52967",authors:[{id:"191086",title:"Dr.",name:"Marcia",surname:"Melo",slug:"marcia-melo",fullName:"Marcia Melo"},{id:"195528",title:"MSc.",name:"Raizza",surname:"Barros Sousa Silva",slug:"raizza-barros-sousa-silva",fullName:"Raizza Barros Sousa Silva"},{id:"195529",title:"BSc.",name:"Laysa",surname:"Freire Franco E Silva",slug:"laysa-freire-franco-e-silva",fullName:"Laysa Freire Franco E Silva"},{id:"195530",title:"MSc.",name:"Beatriz",surname:"Maria De Almeida Braz",slug:"beatriz-maria-de-almeida-braz",fullName:"Beatriz Maria De Almeida Braz"},{id:"195531",title:"Mrs.",name:"Jaqueline",surname:"Dos Santos Sousa",slug:"jaqueline-dos-santos-sousa",fullName:"Jaqueline Dos Santos Sousa"},{id:"195532",title:"Dr.",name:"Saul",surname:"José Semião Santos",slug:"saul-jose-semiao-santos",fullName:"Saul José Semião Santos"},{id:"195576",title:"Dr.",name:"Paulo",surname:"Paes De Andrade",slug:"paulo-paes-de-andrade",fullName:"Paulo Paes De Andrade"}],corrections:null},{id:"52484",title:"Infectious Causes of Abortion, Stillbirth and Neonatal Death in Bitches",doi:"10.5772/65330",slug:"infectious-causes-of-abortion-stillbirth-and-neonatal-death-in-bitches",totalDownloads:2096,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"João Marcelo Azevedo de Paula Antunes, Débora Alves de Carvalho\nFreire, Ilanna Vanessa Pristo de Medeiros Oliveira, Gabriela Hémylin\nFerreira Moura, Larissa de Castro Demoner and Heider Irinaldo\nPereira Ferreira",downloadPdfUrl:"/chapter/pdf-download/52484",previewPdfUrl:"/chapter/pdf-preview/52484",authors:[{id:"191197",title:"Ph.D.",name:"João",surname:"Antunes",slug:"joao-antunes",fullName:"João Antunes"},{id:"191203",title:"MSc.",name:"Débora Alves",surname:"De Carvalho Freire",slug:"debora-alves-de-carvalho-freire",fullName:"Débora Alves De Carvalho Freire"},{id:"191204",title:"MSc.",name:"Ilanna Vanessa",surname:"Pristo De Medeiros Oliveira",slug:"ilanna-vanessa-pristo-de-medeiros-oliveira",fullName:"Ilanna Vanessa Pristo De Medeiros Oliveira"},{id:"191205",title:"BSc.",name:"Gabriela Hémylin",surname:"Ferreira Moura",slug:"gabriela-hemylin-ferreira-moura",fullName:"Gabriela Hémylin Ferreira Moura"},{id:"191207",title:"Dr.",name:"Larissa",surname:"De Castro Demoner",slug:"larissa-de-castro-demoner",fullName:"Larissa De Castro Demoner"},{id:"194801",title:"MSc.",name:"Heider Irinaldo Pereira",surname:"Ferreira",slug:"heider-irinaldo-pereira-ferreira",fullName:"Heider Irinaldo Pereira Ferreira"}],corrections:null},{id:"52758",title:"Mast Cell Tumors",doi:"10.5772/65797",slug:"mast-cell-tumors",totalDownloads:1210,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Yosuke Amagai and Akane Tanaka",downloadPdfUrl:"/chapter/pdf-download/52758",previewPdfUrl:"/chapter/pdf-preview/52758",authors:[{id:"63083",title:"Prof.",name:"Akane",surname:"Tanaka",slug:"akane-tanaka",fullName:"Akane Tanaka"}],corrections:null},{id:"52705",title:"Chronic Mitral Valve Insufficiency in Dogs: Recent Advances in Diagnosis and Treatment",doi:"10.5772/65689",slug:"chronic-mitral-valve-insufficiency-in-dogs-recent-advances-in-diagnosis-and-treatment",totalDownloads:3145,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Sang-II Suh, Dong-Hyun Han, Seung-Gon Lee, Yong-Wei Hung, Ran\nChoi and Changbaig Hyun",downloadPdfUrl:"/chapter/pdf-download/52705",previewPdfUrl:"/chapter/pdf-preview/52705",authors:[{id:"13534",title:"Prof.",name:"Changbaig",surname:"Hyun",slug:"changbaig-hyun",fullName:"Changbaig Hyun"}],corrections:null},{id:"51722",title:"Abnormalities in the Sexual Cycle of Bitches",doi:"10.5772/64648",slug:"abnormalities-in-the-sexual-cycle-of-bitches",totalDownloads:2294,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Ali Risvanli, Halis Ocal and Cahit Kalkan",downloadPdfUrl:"/chapter/pdf-download/51722",previewPdfUrl:"/chapter/pdf-preview/51722",authors:[{id:"189503",title:"Prof.",name:"Ali",surname:"Risvanli",slug:"ali-risvanli",fullName:"Ali Risvanli"},{id:"189518",title:"Prof.",name:"Halis",surname:"Ocal",slug:"halis-ocal",fullName:"Halis Ocal"},{id:"189519",title:"Prof.",name:"Cahit",surname:"Kalkan",slug:"cahit-kalkan",fullName:"Cahit Kalkan"}],corrections:null},{id:"52422",title:"Pursuing Alternative Strategies for Healthier Medical Contraception in Dogs",doi:"10.5772/65331",slug:"pursuing-alternative-strategies-for-healthier-medical-contraception-in-dogs",totalDownloads:1834,totalCrossrefCites:0,totalDimensionsCites:1,signatures:"Rita Payan-Carreira, Paulo Borges and Alain Fontbonne",downloadPdfUrl:"/chapter/pdf-download/52422",previewPdfUrl:"/chapter/pdf-preview/52422",authors:[{id:"38652",title:"Dr.",name:"Rita",surname:"Payan-Carreira",slug:"rita-payan-carreira",fullName:"Rita Payan-Carreira"},{id:"165295",title:"Prof.",name:"Alain",surname:"Fontbonne",slug:"alain-fontbonne",fullName:"Alain Fontbonne"},{id:"195041",title:"Dr.",name:"Paulo",surname:"Borges",slug:"paulo-borges",fullName:"Paulo Borges"}],corrections:null},{id:"52766",title:"Patellar Luxation in Small Animals",doi:"10.5772/65764",slug:"patellar-luxation-in-small-animals",totalDownloads:1491,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Cleuza M.F. Rezende, Renato César Sachetto Tôrres, Anelise\nCarvalho Nepomuceno, Juliana Soares Lara and Jessica Alejandra\nCastro Varón",downloadPdfUrl:"/chapter/pdf-download/52766",previewPdfUrl:"/chapter/pdf-preview/52766",authors:[{id:"68732",title:"Dr.",name:"Cleuza Maria",surname:"de Faria Rezende",slug:"cleuza-maria-de-faria-rezende",fullName:"Cleuza Maria de Faria Rezende"}],corrections:null},{id:"53033",title:"Diffusion Tensor Tractography in Cerebral White Matter",doi:"10.5772/66249",slug:"diffusion-tensor-tractography-in-cerebral-white-matter",totalDownloads:1200,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Mitzi Sarahi Anaya García and Jael Sarahi Hernández Anaya",downloadPdfUrl:"/chapter/pdf-download/53033",previewPdfUrl:"/chapter/pdf-preview/53033",authors:[{id:"190766",title:"Dr.",name:"Mitzi Sarahi",surname:"Anaya Garcia",slug:"mitzi-sarahi-anaya-garcia",fullName:"Mitzi Sarahi Anaya Garcia"},{id:"194994",title:"Dr.",name:"Jael Sarahi",surname:"Hernandez Anaya",slug:"jael-sarahi-hernandez-anaya",fullName:"Jael Sarahi Hernandez Anaya"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},relatedBooks:[{type:"book",id:"6475",title:"Tissue Regeneration",subtitle:null,isOpenForSubmission:!1,hash:"d5ed06a80f0205146aa90d158facefd1",slug:"tissue-regeneration",bookSignature:"Hussein Abdel hay El-Sayed Kaoud",coverURL:"https://cdn.intechopen.com/books/images_new/6475.jpg",editedByType:"Edited by",editors:[{id:"265070",title:"Dr.",name:"Hussein Abdelhay",surname:"Essayed Kaoud",slug:"hussein-abdelhay-essayed-kaoud",fullName:"Hussein Abdelhay Essayed Kaoud"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8288",title:"Bacterial Cattle Diseases",subtitle:null,isOpenForSubmission:!1,hash:"f45b8b4974eb0d7de8719ef6b9146200",slug:"bacterial-cattle-diseases",bookSignature:"Hussein Abdel hay El-Sayed Kaoud",coverURL:"https://cdn.intechopen.com/books/images_new/8288.jpg",editedByType:"Edited by",editors:[{id:"265070",title:"Dr.",name:"Hussein Abdelhay",surname:"Essayed Kaoud",slug:"hussein-abdelhay-essayed-kaoud",fullName:"Hussein Abdelhay Essayed Kaoud"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3423",title:"Insights from Veterinary Medicine",subtitle:null,isOpenForSubmission:!1,hash:"8712769decefe74bd752ce339f476964",slug:"insights-from-veterinary-medicine",bookSignature:"Rita Payan-Carreira",coverURL:"https://cdn.intechopen.com/books/images_new/3423.jpg",editedByType:"Edited by",editors:[{id:"38652",title:"Dr.",name:"Rita",surname:"Payan-Carreira",slug:"rita-payan-carreira",fullName:"Rita Payan-Carreira"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"314",title:"Regenerative Medicine and Tissue Engineering",subtitle:"Cells and Biomaterials",isOpenForSubmission:!1,hash:"bb67e80e480c86bb8315458012d65686",slug:"regenerative-medicine-and-tissue-engineering-cells-and-biomaterials",bookSignature:"Daniel Eberli",coverURL:"https://cdn.intechopen.com/books/images_new/314.jpg",editedByType:"Edited by",editors:[{id:"6495",title:"Dr.",name:"Daniel",surname:"Eberli",slug:"daniel-eberli",fullName:"Daniel Eberli"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"74918",slug:"corrigendum-to-a-hybrid-control-approach-based-on-the-combination-of-pid-control-with-lqr-optimal-co",title:"Corrigendum to: A Hybrid Control Approach Based on the Combination of PID Control with LQR Optimal Control",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/74918.pdf",downloadPdfUrl:"/chapter/pdf-download/74918",previewPdfUrl:"/chapter/pdf-preview/74918",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/74918",risUrl:"/chapter/ris/74918",chapter:{id:"74293",slug:"a-hybrid-control-approach-based-on-the-combination-of-pid-control-with-lqr-optimal-control",signatures:"Ibrahim K. Mohammed",dateSubmitted:"July 8th 2020",dateReviewed:"November 4th 2020",datePrePublished:"December 3rd 2020",datePublished:null,book:{id:"9887",title:"Advance Innovation and Expansion of PID Controllers",subtitle:null,fullTitle:"Advance Innovation and Expansion of PID Controllers",slug:null,publishedDate:null,bookSignature:"Prof. Wei Wang",coverURL:"https://cdn.intechopen.com/books/images_new/9887.jpg",licenceType:"CC BY 3.0",editedByType:null,editors:[{id:"101176",title:"Prof.",name:"Wei",middleName:null,surname:"Wang",slug:"wei-wang",fullName:"Wei Wang"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:null}},chapter:{id:"74293",slug:"a-hybrid-control-approach-based-on-the-combination-of-pid-control-with-lqr-optimal-control",signatures:"Ibrahim K. Mohammed",dateSubmitted:"July 8th 2020",dateReviewed:"November 4th 2020",datePrePublished:"December 3rd 2020",datePublished:null,book:{id:"9887",title:"Advance Innovation and Expansion of PID Controllers",subtitle:null,fullTitle:"Advance Innovation and Expansion of PID Controllers",slug:null,publishedDate:null,bookSignature:"Prof. Wei Wang",coverURL:"https://cdn.intechopen.com/books/images_new/9887.jpg",licenceType:"CC BY 3.0",editedByType:null,editors:[{id:"101176",title:"Prof.",name:"Wei",middleName:null,surname:"Wang",slug:"wei-wang",fullName:"Wei Wang"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:null},book:{id:"9887",title:"Advance Innovation and Expansion of PID Controllers",subtitle:null,fullTitle:"Advance Innovation and Expansion of PID Controllers",slug:null,publishedDate:null,bookSignature:"Prof. Wei Wang",coverURL:"https://cdn.intechopen.com/books/images_new/9887.jpg",licenceType:"CC BY 3.0",editedByType:null,editors:[{id:"101176",title:"Prof.",name:"Wei",middleName:null,surname:"Wang",slug:"wei-wang",fullName:"Wei Wang"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"6646",leadTitle:null,title:"Artificial Intelligence",subtitle:"Emerging Trends and Applications",reviewType:"peer-reviewed",abstract:"Artificial intelligence (AI) is taking an increasingly important role in our society. From cars, smartphones, airplanes, consumer applications, and even medical equipment, the impact of AI is changing the world around us. The ability of machines to demonstrate advanced cognitive skills in taking decisions, learn and perceive the environment, predict certain behavior, and process written or spoken languages, among other skills, makes this discipline of paramount importance in today's world. Although AI is changing the world for the better in many applications, it also comes with its challenges. This book encompasses many applications as well as new techniques, challenges, and opportunities in this fascinating area.",isbn:"978-1-78923-365-0",printIsbn:"978-1-78923-364-3",pdfIsbn:"978-1-83881-615-5",doi:"10.5772/intechopen.71805",price:139,priceEur:155,priceUsd:179,slug:"artificial-intelligence-emerging-trends-and-applications",numberOfPages:464,isOpenForSubmission:!1,hash:"133520f4918b2d1f1c304ffeadba89a9",bookSignature:"Marco Antonio Aceves-Fernandez",publishedDate:"June 27th 2018",coverURL:"https://cdn.intechopen.com/books/images_new/6646.jpg",keywords:null,numberOfDownloads:18641,numberOfWosCitations:17,numberOfCrossrefCitations:23,numberOfDimensionsCitations:41,numberOfTotalCitations:81,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"October 26th 2017",dateEndSecondStepPublish:"November 16th 2017",dateEndThirdStepPublish:"January 15th 2018",dateEndFourthStepPublish:"April 5th 2018",dateEndFifthStepPublish:"June 4th 2018",remainingDaysToSecondStep:"3 years",secondStepPassed:!0,currentStepOfPublishingProcess:5,editedByType:"Edited by",kuFlag:!1,biosketch:null,coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"24555",title:"Dr.",name:"Marco Antonio",middleName:null,surname:"Aceves-Fernandez",slug:"marco-antonio-aceves-fernandez",fullName:"Marco Antonio Aceves-Fernandez",profilePictureURL:"https://mts.intechopen.com/storage/users/24555/images/system/24555.jpg",biography:"Dr. Marco A. Aceves-Fernandez obtained his BSc (Eng) in Telematics from the Universidad de Colima, Mexico. He obtained both his MSc and PhD from the University of Liverpool, England, in the field of Intelligent Systems. He is full professor at the Universidad Autonoma de Queretaro, Mexico. He has been a recognized member of the National System of Researchers (SNI) since 2009. He has published more than eighty research papers as well as a number of book chapters and congress papers. He has contributed in more than twenty funded research projects, both academic and industrial, in the area of artificial intelligence, including environmental, biomedical, automotive, aviation, consumer, and robotics applications. He is also honorary president at the Mexican Association of Embedded Systems (AMESE), a senior member of the Institute of Electrical and Electronics Engineer (IEEE), and a board member for many institutions and associations. His research interests include intelligent and embedded systems.",institutionString:"Universidad Autonoma de Queretaro",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"3",institution:null}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"87",title:"Artificial Intelligence",slug:"computer-and-information-science-artificial-intelligence"}],chapters:[{id:"61601",title:"Biologically Inspired Intelligence with Applications on Robot Navigation",slug:"biologically-inspired-intelligence-with-applications-on-robot-navigation",totalDownloads:611,totalCrossrefCites:1,authors:[{id:"36311",title:"Dr.",name:"Chaomin",surname:"Luo",slug:"chaomin-luo",fullName:"Chaomin Luo"},{id:"154994",title:"Dr",name:null,surname:"Li",slug:"li",fullName:"Li"},{id:"220894",title:"Prof.",name:"Gene Eu (Ching Yuh)",surname:"Jan",slug:"gene-eu-(ching-yuh)-jan",fullName:"Gene Eu (Ching Yuh) Jan"},{id:"259507",title:"Dr.",name:"Zhenzhong",surname:"Chu",slug:"zhenzhong-chu",fullName:"Zhenzhong Chu"}]},{id:"60337",title:"A Modified Neuro-Fuzzy System Using Metaheuristic Approaches for Data Classification",slug:"a-modified-neuro-fuzzy-system-using-metaheuristic-approaches-for-data-classification",totalDownloads:1271,totalCrossrefCites:6,authors:[{id:"24637",title:"Dr.",name:"Mohd Najib",surname:"Mohd Salleh",slug:"mohd-najib-mohd-salleh",fullName:"Mohd Najib Mohd Salleh"},{id:"241321",title:"Mrs.",name:"Noureen",surname:"Talpur",slug:"noureen-talpur",fullName:"Noureen Talpur"}]},{id:"60847",title:"Differential Evolution Algorithm in the Construction of Interpretable Classification Models",slug:"differential-evolution-algorithm-in-the-construction-of-interpretable-classification-models",totalDownloads:848,totalCrossrefCites:1,authors:[{id:"234503",title:"Dr.",name:"Juana",surname:"Canul-Reich",slug:"juana-canul-reich",fullName:"Juana Canul-Reich"},{id:"241466",title:"Dr.",name:"Rafael",surname:"Rivera-Lopez",slug:"rafael-rivera-lopez",fullName:"Rafael Rivera-Lopez"}]},{id:"60354",title:"Advanced Content and Interface Personalization through Conversational Behavior and Affective Embodied Conversational Agents",slug:"advanced-content-and-interface-personalization-through-conversational-behavior-and-affective-embodie",totalDownloads:602,totalCrossrefCites:0,authors:[{id:"231147",title:"Associate Prof.",name:"Matej",surname:"Rojc",slug:"matej-rojc",fullName:"Matej Rojc"},{id:"231962",title:"Prof.",name:"Zdravko",surname:"Kačič",slug:"zdravko-kacic",fullName:"Zdravko Kačič"},{id:"231965",title:"Dr.",name:"Izidor",surname:"Mlakar",slug:"izidor-mlakar",fullName:"Izidor Mlakar"}]},{id:"60696",title:"High Performance Technology in Algorithmic Cryptography",slug:"high-performance-technology-in-algorithmic-cryptography",totalDownloads:662,totalCrossrefCites:0,authors:[{id:"231593",title:"M.Sc.",name:"Arturo",surname:"Lezama-León",slug:"arturo-lezama-leon",fullName:"Arturo Lezama-León"},{id:"234657",title:"Prof.",name:"José",surname:"Montes-Olguín",slug:"jose-montes-olguin",fullName:"José Montes-Olguín"},{id:"234665",title:"MSc.",name:"Evangelina",surname:"Lezama-León",slug:"evangelina-lezama-leon",fullName:"Evangelina Lezama-León"},{id:"242673",title:"MSc.",name:"José Juan",surname:"Zarate-Corona",slug:"jose-juan-zarate-corona",fullName:"José Juan Zarate-Corona"},{id:"242674",title:"Prof.",name:"Juan Ángel",surname:"Rosales-Alba",slug:"juan-angel-rosales-alba",fullName:"Juan Ángel Rosales-Alba"},{id:"242677",title:"Prof.",name:"Ma. De La Luz",surname:"Carrillo González",slug:"ma.-de-la-luz-carrillo-gonzalez",fullName:"Ma. De La Luz Carrillo González"}]},{id:"61127",title:"A Deterministic Algorithm for Arabic Character Recognition Based on Letter Properties",slug:"a-deterministic-algorithm-for-arabic-character-recognition-based-on-letter-properties",totalDownloads:638,totalCrossrefCites:0,authors:[{id:"223522",title:"Dr.",name:"Evon",surname:"Abu-Taieh",slug:"evon-abu-taieh",fullName:"Evon Abu-Taieh"},{id:"250079",title:"Dr.",name:"Auhood",surname:"Abd. Alfaries",slug:"auhood-abd.-alfaries",fullName:"Auhood Abd. Alfaries"},{id:"250080",title:"Dr.",name:"Nabeel",surname:"M. Zanoon",slug:"nabeel-m.-zanoon",fullName:"Nabeel M. Zanoon"},{id:"250082",title:"Dr.",name:"Issam",surname:"H. Al Hadid",slug:"issam-h.-al-hadid",fullName:"Issam H. Al Hadid"},{id:"250083",title:"Dr.",name:"Alia",surname:"M. Abu-Tayeh",slug:"alia-m.-abu-tayeh",fullName:"Alia M. Abu-Tayeh"}]},{id:"59823",title:"Human-AI Synergy in Creativity and Innovation",slug:"human-ai-synergy-in-creativity-and-innovation",totalDownloads:755,totalCrossrefCites:0,authors:[{id:"235899",title:"Dr.",name:"Tony",surname:"McCaffrey",slug:"tony-mccaffrey",fullName:"Tony McCaffrey"}]},{id:"59582",title:"Min k-Cut for Asset Selection in Risk-Based Portfolio Strategies",slug:"min-k-cut-for-asset-selection-in-risk-based-portfolio-strategies",totalDownloads:519,totalCrossrefCites:0,authors:[{id:"232637",title:"Prof.",name:"Saejoon",surname:"Kim",slug:"saejoon-kim",fullName:"Saejoon Kim"},{id:"240890",title:"Mr.",name:"Soong",surname:"Kim",slug:"soong-kim",fullName:"Soong Kim"}]},{id:"60468",title:"Virtual Reality for Urban Sound Design: A Tool for Architects and Urban Planners",slug:"virtual-reality-for-urban-sound-design-a-tool-for-architects-and-urban-planners",totalDownloads:957,totalCrossrefCites:0,authors:[{id:"225606",title:"Ph.D. Student",name:"Josep",surname:"Llorca",slug:"josep-llorca",fullName:"Josep Llorca"}]},{id:"60772",title:"Blockchain: The Next Breakthrough in the Rapid Progress of AI",slug:"blockchain-the-next-breakthrough-in-the-rapid-progress-of-ai",totalDownloads:1592,totalCrossrefCites:4,authors:[{id:"230468",title:"Prof.",name:"Spyros",surname:"Makridakis",slug:"spyros-makridakis",fullName:"Spyros Makridakis"},{id:"241034",title:"Mr.",name:"Antonis",surname:"Polemitis",slug:"antonis-polemitis",fullName:"Antonis Polemitis"},{id:"241035",title:"Dr.",name:"George",surname:"Giaglis",slug:"george-giaglis",fullName:"George Giaglis"},{id:"241036",title:"Prof.",name:"Soulla",surname:"Louca",slug:"soulla-louca",fullName:"Soulla Louca"}]},{id:"60234",title:"Augmenting Reality with Intelligent Interfaces",slug:"augmenting-reality-with-intelligent-interfaces",totalDownloads:1169,totalCrossrefCites:1,authors:[{id:"233008",title:"Dr.",name:"David",surname:"Kaufman",slug:"david-kaufman",fullName:"David Kaufman"},{id:"233011",title:"Mr.",name:"Dov",surname:"Schafer",slug:"dov-schafer",fullName:"Dov Schafer"}]},{id:"59614",title:"The Today Tendency of Sentiment Classification",slug:"the-today-tendency-of-sentiment-classification",totalDownloads:856,totalCrossrefCites:0,authors:[{id:"230428",title:"Dr.",name:"Vo",surname:"Ngoc Phu",slug:"vo-ngoc-phu",fullName:"Vo Ngoc Phu"},{id:"240267",title:"Dr.",name:"Tran",surname:"Vo Thi Ngoc",slug:"tran-vo-thi-ngoc",fullName:"Tran Vo Thi Ngoc"}]},{id:"61918",title:"A Multilevel Genetic Algorithm for the Maximum Satisfaction Problem",slug:"a-multilevel-genetic-algorithm-for-the-maximum-satisfaction-problem",totalDownloads:501,totalCrossrefCites:0,authors:[{id:"213633",title:"Dr.",name:"Noureddine",surname:"Bouhmala",slug:"noureddine-bouhmala",fullName:"Noureddine Bouhmala"}]},{id:"61389",title:"Artificial Intelligence Application in Machine Condition Monitoring and Fault Diagnosis",slug:"artificial-intelligence-application-in-machine-condition-monitoring-and-fault-diagnosis",totalDownloads:1512,totalCrossrefCites:4,authors:[{id:"230462",title:"Dr.",name:"Yasir",surname:"Ali",slug:"yasir-ali",fullName:"Yasir Ali"}]},{id:"60945",title:"Normal Versus Abnormal ECG Classification by the Aid of Deep Learning",slug:"normal-versus-abnormal-ecg-classification-by-the-aid-of-deep-learning",totalDownloads:820,totalCrossrefCites:1,authors:[{id:"233804",title:"Prof.",name:"Jun",surname:"Dong",slug:"jun-dong",fullName:"Jun Dong"},{id:"233896",title:"Dr.",name:"Lin-Peng",surname:"Jin",slug:"lin-peng-jin",fullName:"Lin-Peng Jin"}]},{id:"60375",title:"A Quantitative Approach for Web Usability Using Eye Tracking Data",slug:"a-quantitative-approach-for-web-usability-using-eye-tracking-data",totalDownloads:487,totalCrossrefCites:0,authors:[{id:"232939",title:"Dr.",name:"Francisco",surname:"Lopez-Orozco",slug:"francisco-lopez-orozco",fullName:"Francisco Lopez-Orozco"},{id:"232945",title:"Dr.",name:"Rogelio",surname:"Florencia-Juarez",slug:"rogelio-florencia-juarez",fullName:"Rogelio Florencia-Juarez"}]},{id:"60075",title:"Deep Learning Models for Predicting Phenotypic Traits and Diseases from Omics Data",slug:"deep-learning-models-for-predicting-phenotypic-traits-and-diseases-from-omics-data",totalDownloads:968,totalCrossrefCites:2,authors:[{id:"235977",title:"Dr.",name:"Pingzhao",surname:"Hu",slug:"pingzhao-hu",fullName:"Pingzhao Hu"},{id:"240941",title:"Dr.",name:"Yang",surname:"Wang",slug:"yang-wang",fullName:"Yang Wang"},{id:"240942",title:"MSc.",name:"Md. Mohaiminul",surname:"Islam",slug:"md.-mohaiminul-islam",fullName:"Md. Mohaiminul Islam"}]},{id:"60998",title:"Can Reinforcement Learning Be Applied to Surgery?",slug:"can-reinforcement-learning-be-applied-to-surgery-",totalDownloads:577,totalCrossrefCites:0,authors:[{id:"247377",title:"Dr.",name:"Masakazu",surname:"Sato",slug:"masakazu-sato",fullName:"Masakazu Sato"},{id:"247592",title:"Dr.",name:"Kaori",surname:"Koga",slug:"kaori-koga",fullName:"Kaori Koga"},{id:"247594",title:"Prof.",name:"Tomoyuki",surname:"Fujii",slug:"tomoyuki-fujii",fullName:"Tomoyuki Fujii"},{id:"247597",title:"Prof.",name:"Yutaka",surname:"Osuga",slug:"yutaka-osuga",fullName:"Yutaka Osuga"}]},{id:"60286",title:"Application of AI in Modeling of Real System in Chemistry",slug:"application-of-ai-in-modeling-of-real-system-in-chemistry",totalDownloads:676,totalCrossrefCites:1,authors:[{id:"235179",title:"Dr.",name:"Ahmadi",surname:"Azqhandi",slug:"ahmadi-azqhandi",fullName:"Ahmadi Azqhandi"}]},{id:"60761",title:"Application of AI in Chemical Engineering",slug:"application-of-ai-in-chemical-engineering",totalDownloads:1254,totalCrossrefCites:2,authors:[{id:"236173",title:"Assoc. Prof.",name:"Zeinab",surname:"Hajjar",slug:"zeinab-hajjar",fullName:"Zeinab Hajjar"},{id:"241594",title:"Dr.",name:"Shokoufe",surname:"Tayyebi",slug:"shokoufe-tayyebi",fullName:"Shokoufe Tayyebi"},{id:"241595",title:"Dr.",name:"Mohammad Hosein",surname:"Eghbal Ahmadi",slug:"mohammad-hosein-eghbal-ahmadi",fullName:"Mohammad Hosein Eghbal Ahmadi"}]},{id:"60491",title:"Application of Biomedical Text Mining",slug:"application-of-biomedical-text-mining",totalDownloads:867,totalCrossrefCites:0,authors:[{id:"233895",title:"Ph.D.",name:"Lj",surname:"Gong",slug:"lj-gong",fullName:"Lj Gong"}]},{id:"61243",title:"Static/Dynamic Zoometry Concept to Design Cattle Facilities Using Back Propagation Neural Network (BPNN)",slug:"static-dynamic-zoometry-concept-to-design-cattle-facilities-using-back-propagation-neural-network-bp",totalDownloads:513,totalCrossrefCites:0,authors:[{id:"234186",title:"Ph.D.",name:"Sugiono",surname:"Sugiono",slug:"sugiono-sugiono",fullName:"Sugiono Sugiono"}]}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"220806",firstName:"Julian",lastName:"Virag",middleName:null,title:"Mr.",imageUrl:"https://mts.intechopen.com/storage/users/220806/images/6089_n.jpg",email:"julian@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"7723",title:"Artificial Intelligence",subtitle:"Applications in Medicine and Biology",isOpenForSubmission:!1,hash:"a3852659e727f95c98c740ed98146011",slug:"artificial-intelligence-applications-in-medicine-and-biology",bookSignature:"Marco Antonio Aceves-Fernandez",coverURL:"https://cdn.intechopen.com/books/images_new/7723.jpg",editedByType:"Edited by",editors:[{id:"24555",title:"Dr.",name:"Marco Antonio",surname:"Aceves-Fernandez",slug:"marco-antonio-aceves-fernandez",fullName:"Marco Antonio Aceves-Fernandez"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9963",title:"Advances and Applications in Deep Learning",subtitle:null,isOpenForSubmission:!1,hash:"0d51ba46f22e55cb89140f60d86a071e",slug:"advances-and-applications-in-deep-learning",bookSignature:"Marco Antonio Aceves-Fernandez",coverURL:"https://cdn.intechopen.com/books/images_new/9963.jpg",editedByType:"Edited by",editors:[{id:"24555",title:"Dr.",name:"Marco Antonio",surname:"Aceves-Fernandez",slug:"marco-antonio-aceves-fernandez",fullName:"Marco Antonio Aceves-Fernandez"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8841",title:"Deterministic Artificial Intelligence",subtitle:null,isOpenForSubmission:!1,hash:"bd65f564ea0b77f91dea36cfcbaa1da7",slug:"deterministic-artificial-intelligence",bookSignature:"Timothy Sands",coverURL:"https://cdn.intechopen.com/books/images_new/8841.jpg",editedByType:"Edited by",editors:[{id:"258189",title:"Prof.",name:"Timothy",surname:"Sands",slug:"timothy-sands",fullName:"Timothy Sands"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7726",title:"Swarm Intelligence",subtitle:"Recent Advances, New Perspectives and Applications",isOpenForSubmission:!1,hash:"e7ea7e74ce7a7a8e5359629e07c68d31",slug:"swarm-intelligence-recent-advances-new-perspectives-and-applications",bookSignature:"Javier Del Ser, Esther Villar and Eneko Osaba",coverURL:"https://cdn.intechopen.com/books/images_new/7726.jpg",editedByType:"Edited by",editors:[{id:"49813",title:"Dr.",name:"Javier",surname:"Del Ser",slug:"javier-del-ser",fullName:"Javier Del Ser"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7795",title:"Artificial Intelligence",subtitle:"Scope and Limitations",isOpenForSubmission:!1,hash:"7e536b4fe8982ca9015228fe6f58c6ea",slug:"artificial-intelligence-scope-and-limitations",bookSignature:"Dinesh G. Harkut",coverURL:"https://cdn.intechopen.com/books/images_new/7795.jpg",editedByType:"Edited by",editors:[{id:"216122",title:"Dr.",name:"Dinesh G.",surname:"Harkut",slug:"dinesh-g.-harkut",fullName:"Dinesh G. Harkut"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8523",title:"Advanced Analytics and Artificial Intelligence Applications",subtitle:null,isOpenForSubmission:!1,hash:"277ac6770bdb7c0841ffdba2b1de348d",slug:"advanced-analytics-and-artificial-intelligence-applications",bookSignature:"Ali Soofastaei",coverURL:"https://cdn.intechopen.com/books/images_new/8523.jpg",editedByType:"Edited by",editors:[{id:"257455",title:"Dr.",name:"Ali",surname:"Soofastaei",slug:"ali-soofastaei",fullName:"Ali Soofastaei"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8598",title:"Enhanced Expert Systems",subtitle:null,isOpenForSubmission:!1,hash:"3cd73aedbaf8bde7433fb0f3d56203cd",slug:"enhanced-expert-systems",bookSignature:"Petrică Vizureanu",coverURL:"https://cdn.intechopen.com/books/images_new/8598.jpg",editedByType:"Edited by",editors:[{id:"12354",title:"Prof.",name:"Petrică",surname:"Vizureanu",slug:"petrica-vizureanu",fullName:"Petrică Vizureanu"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"50544",title:"Algal Nanoparticles: Synthesis and Biotechnological Potentials",doi:"10.5772/62909",slug:"algal-nanoparticles-synthesis-and-biotechnological-potentials",body:'\nNanotechnology is a vibrant and developing area of science, engineering, and technology accomplished at the nanoscale level. The products of nanotechnology are nanoparticles or nanomaterials (NPs), lying in the range of 10−9 m and having dimensions of 1–100 nm. NPs are categorized into three types: natural nanoparticles, incidental nanoparticles, and engineered nanoparticles [1]. The large surface-to-volume ratio of nanoparticles, their ability of easy interaction with other particles, and several other features make them as an attractive tool in various fields. NPs are widely used in electronic, cosmetic, biomedical, and biotechnological applications. The efficient crystallographic and physiochemical properties of NPs make nanotechnology as an excellent area to focus. The synthesis of NPs can be achieved by some physical methods and chemical methods. The traditional and commonly used method for nanoparticles synthesis is wet method. In chemical synthesis, nanoparticles are grown in a liquid medium containing various reactants particularly reducing agents such as sodium borohydride [2], potassium bitartartarate [3], methoxypolyethylene glycol [4], or hydrazine [5]. Some stabilizing agents such as sodium dodecyl benzyl sulfate [5] or polyvinyl pyrrolidone [3] are added to the reaction mixture to prevent the agglomeration of metallic nanoparticles. Most commonly used chemical methods are chemical reduction [6], electrochemical techniques [7], and photochemical reactions in reverse micelles [8]. Commonly used physical methods are attrition and pyrolysis. Attrition involves grinding of the particles by a size-reducing mechanism. The particles are then air-classified, and oxidized nanoparticles are recovered. Pyrolysis involves burning of the precursor by passing them through an orifice at high pressure. The ash obtained is air classified to recover the oxidized nanoparticles [9]. Chemical methods are of low cost for high volume, and their major drawbacks include contamination from precursor chemicals, use of toxic solvents, and generation of hazardous by products, and the demerits of physical methods are low production rate, high cost of production, and high energy consumption [5]. There is need for replacing the toxic ingredients with environmentally safe method for synthesizing NPs. To overcome this, researchers are focusing on employing biological method for the synthesis of nanoparticles. They are generally cost effective, nontoxic, and ecofriendly [10]. So far, several plant extract [11], bacteria [12], fungi [13], enzymes [14], and algae [15] have been used for the synthesis of NPs. To our surprise, an emerging trend of synthesizing NPs using algae is developing in the recent years.
\nAlgae are economically and ecologically important group of photosynthetic organism. They are unicellular or multicellular organisms dwelling in different environment such as freshwater, marine water, or surface of moist rocks [16–18]. Algae are categorized as microalgae (microscopic) and macroalgae (macroscopic). They play a key role in medical, pharmaceutical, agriculture, aquaculture, cosmetics applications. Algae are valuable source for various commercial products such as natural dyes and biofuels [19–22]. Till now, for the biosynthesis of metallic NPs, different group of algae such as Chlorophyceae, Phaeophyceae, Cyanophyceae, Rhodophyceae, and others (diatoms and euglenoids) have been used [23]. The ability of algae to accumulate metals and reduce metal ions makes them the superior contender for the biosynthesis of nanoparticles. Furthermore, algae are relatively convenient and easy to handle, along with several other advantages such as synthesis at low temperature with greater energy efficiency, less toxicity, and risk to the environment. In physical and chemical method, different commercially available surfactants were used as templates and capping agents in NPs synthesis with different morphologies. Removal of the residual components becomes a major issue. Considering this utilization of naturally eco-friendly methods having been developed which involves the synthesis of NP using different biological sources which could naturally modify the shape or size of a crystal with superior quality [24].
\nAmong the biological materials, algae are called as ―bionanofactories‖ because both the live and dead dried biomasses were used for the synthesis of metallic nanoparticles [25]. Several algae such as
Different types of nanoparticles.
There are two different types of NPs, inorganic NPs and organic NPs. The inorganic NPs include metal and metal oxides, which are potent antibacterial agents [31] (Figure 1). Metal oxide nanoparticles such as silver (Ag), iron oxide (Fe3O4), titanium oxide (TiO2), copper oxide (CuO), and zinc oxide (ZnO) are certain examples of inorganic NPs. Organic NPs includes poly-ɛ-lysine, quaternary ammonium compounds, cationic quaternary polyelectrolytes, N-halamine compounds, and chitosan . Organic nanoparticles are generally less stable at high temperatures. Due this reason, inorganic nanoparticles are more preferred as antimicrobial polymers [32].
\nSo far, there are different types of inorganic metals and metal oxide NPs, which have been studied. Some important examples are detailed (Figure 2)
\nTypes of inorganic nanoparticles.
Silver nanoparticle (AgNP) is the most widely used antimicrobial agent against many bacteria, fungi, and viruses [33]. The antimicrobial activity AgNP was found to be size dependent, and larger particles are less active than smaller one against many pathogens in both
Titanium oxide (TiO2) is found to be effective against both Gram-positive/Gram-negative bacteria, viral, and parasitic infections [48, 49]. They are photocatalytic; their toxicity can be induced by visible light, or UV light, generates ROS [50]. TiO2 is an effective bactericidal agent and a potent sporicidal agent against wide range of bacteria [51].
\nZnO nanoparticles (ZnONPs) are another broad spectrum antibacterial agent, based on concentration and size of the NPs, and they are effective against methicillin-sensitive
Iron oxide is generally inactive in their bulk form. Reducing their size to nanoscale makes them a potential antimicrobial agent. Iron oxide nanoparticles-coated surfaces prevent the adhesion and colonization of Gram-positive and Gram-negative bacteria [56].
\nAs compared to Ag, Au nanoparticles are less effective and lack antimicrobial properties when used alone but found to be effective when used in combination with antibiotics such as ampicillin [57, 58], vancomycin [59], and lysozyme (an antibacterial enzyme) [60]. The Au nanoparticles can also be used in combination with nonantibiotic molecules such as amino substituted pyrimidines [61] and citrate, which induces the generation of ROS and mutations, hence used in cancer therapy [62].
\nDespite copper oxide (CuO) nanoparticles are used as antibacterial agents, they are less effective than that of Ag and ZnO. So a comparatively higher concentration is required to get desired results. But some bacteria are more susceptible to CuO than Ag. For example,
Magnesium oxide (MgO) nanoparticles are efficient antimicrobial agent exhibiting bactericidal activity against both Gram-positive and Gram-negative bacteria, spores and viruses. The MgO NPs can be prepared from available and economical precursors. Along with membrane disruption and ROS generation, it also inhibits the essential enzymes of bacteria [50, 67].
\nNitric oxide (NO) nanoparticles are highly reactive antibacterial agent. Similar to other nanoparticles, the activity of NO is also size dependent [68, 69]. The mode of inhibition is by the production of reactive nitrogen species (RNS) rather than ROS. They are effective against MRSA
Some of the well-known examples of organic NPs are discussed below (Figure 3).
\nTypes of organic nanoparticles.
Poly-ɛ-lysine, a cationic homopeptide of L-lysine is effective against Gram-positive bacteria and spores of
Quaternary ammonium compounds are well known disinfectants and their antimicrobial property dependents on the chain length. The positively charged moieties of the compounds are attached to the negatively charged bacterial membrane by weak electrostatic interaction, followed by the insertion of hydrophobic tail of the compound in to the bacterial hydrophobic membrane core leading to the denaturation of structural proteins and enzymes [73].
\nThey are synthesized from methacrylic monomers such as 2-(dimethylamino) ethyl methacrylate and majority of them are derivatives of acrylic and methacrylic compounds. These molecules possess a wide range of biological applications due to their structural flexibility through the alteration of hydrophobicity, molecular weight, surface charge and other factors [74].
\nN-halamine compounds are formed by the halogenation of imide amide or amine groups with one or more nitrogen–halogen covalent bonds. These are high stable compounds releasing free active halogen groups slowly in to the environment leading to the inhibition or inactivation of the microbial cells [75].
\nChitosan NPs are biocompatible, nontoxic, and have the ability to act as absorption enhancer. These characteristics make the chitosan nanoparticles as an effective antimicrobial agent with broad spectrum activity against a wide range of bacteria, fungi and viruses. The antibacterial activity of chitosan nanoparticles depends on several factors such as pH and the nature of solvent [76, 77]. The use of chitosan along with metal nanoparticles is not feasible since chitosan reduced the activity of metal nanoparticles such as Zn. It can be used in combination with antibiotics [76, 78]. Even though some studies state that the interaction of cells with chitosan lead to membrane destabilization, followed by lysis and cell death, the detailed mode of action is unclear [79].
\n\nThe abundance and ease of availability of algae make them good and worthwhile sources for the synthesis of metallic nanoparticles [80]. Synthesis of nanoparticles using algae can be performed in three important steps, (i) preparation of algal extract in water or in an organic solvent by heating or boiling it for a certain duration, (ii) preparation of molar solutions of ionic metallic compounds and (iii) incubation of algal solutions and molar solutions of ionic metallic compounds followed either by continuous stirring or without stirring for a certain duration under controlled conditions [10, 30]. The synthesis of NPs is dose dependent and it is also related to the type of algae used. There are a variety of biomolecules responsible for the reduction of metals which include polysaccharides, peptides, and pigments. Stabilizing and capping the metal nanoparticles in aqueous solutions is done by proteins through amino groups or cysteine residues and sulfated polysaccharides [81]. Synthesis of nanoparticles using algae takes comparatively shorter time period than the other biosynthesizing methods [10, 30]. So far, several seaweeds (
The biomedical application of algal-synthesized NPs is significantly becoming more important due to their antibacterial, antifungal, anti-cancer, and wound healing activity. They are given (Figure 4).
\nApplications of algal-synthesized nanoparticles.
Algal-synthesized NPs are known to possess efficient antibacterial activity (Figure 5; Table 1). Brown alga (
Different nanoparticles and their mode of inhibition against bacteria.
AgNPs synthesized using
Algae | \nNPs | \nSize | \nShape | \nIntracellular (IC) or extracellular (EC) | \nPathogens | \nReferences | \n
---|---|---|---|---|---|---|
CuO | \n5–45 nm | \nSpherical and elongated | \nIC | \n[85] | \n||
Au | \n3.85–77.13 nm | \nSpherical | \nIC | \nMRSA | \n[86] | \n|
AgCl | \n18–42 nm | \nSpherical | \nIC | \n[87] | \n||
Ag | \n4 and 6 nm | \nSpherical | \nIC | \n[88] | \n||
Ag | \n5–70 nm | \nSpherical | \nIC | \n\n | [89] | \n|
Ag | \n5–25 nm | \nSpherical and triangle | \n\n | [90] | \n||
Ag | \n– | \n– | \n\n | [91] | \n||
Ag | \n28–41 nm | \nSpherical | \nIC | \n[96] | \n||
Au | \n60 nm | \nTriangle, rectangle & square | \nIC | \n[97] | \n||
Ag | \n10–72 nm | \nSpherical | \nIC | \n[99] | \n||
Ag | \n6 nm | \nSpherical | \nIC | \n[100] | \n||
Au | \n5 nm | \n– | \nIC | \n[101] | \n
Different types of algal-synthesized NPs and its antibacterial activity.
The aqueous extract of red marine algae
Nanoparticle | \nTarget organism | \nReferences | \n
Silver nanoparticles | \n[112, 113] | \n|
Bismuth oxide aqueous colloidal nanoparticles | \n[114, 115] | \n|
Nano-oil formulation from | \n[116] | \n|
Nano-emulsion (detergent, oil, and water) in combination with cetylpyridinium chloride | \n[117] | \n|
Silver- and gold-incorporated polyurethane, polycaprolactam, polycarbonate, and polymethylmethacrylate | \n[118] | \n|
Silver nanoparticles in combination with nystatin and chlorhexidine | \n[119] | \n|
Silver nanoparticle and 12-methacryloyloxydodecylpyridinium bromide (MDPB) | \nDental plaque microcosm biofilms | \n[120, 121] | \n
Copper | \n[108] | \n|
Zinc | \n[122] | \n|
Magnetite nanoparticles | \n[56] | \n|
oxide/oleic acid core/shell nanostructures | \n[123, 124] | \n|
Zinc and copper oxide nanoparticles | \n[125] | \n|
Zerovalent bismuth nanoparticle | \n[114] | \n|
Dextran sulfate nanoparticle complex containing ofloxacin and levofloxacin | \n[126] | \n|
PEG-stabilized lipid nanoparticles loaded with terpinen-4-ol | \n[127] | \n|
Magnesium fluoride nanoparticles | \n[128–130] | \n|
Yttrium fluoride nanoparticles | \n[131] | \n|
Iron oxide/oleic acid in combination with essential oil from | \n[132] | \n|
Gold nanoparticles and methylene blue | \n[133] | \n|
Starch-stabilized silver nanoparticles | \n[134] | \n|
Iron oxide–oleic acid nanofluid | \n[124] | \n|
Quaternary ammonium polyethylenimine nanoparticles | \nOral biofilms | \n[41] | \n
Zinc oxide nanoparticles, chitosan nanoparticles, and combination of both | \n[135] | \n|
Polyurethane nanocomposite | \n[136] | \n
Antibiofilm activity of different NPs against microbial pathogen.
Algal-synthesized NPs were used as efficient antifungal agents. Only countable number of work has been carried out in this aspect. This includes the synthesis AgNPs using the aqueous extract of red seaweed
In a work done by Boca et al. [104] synthesized chitosan-coated silver nano-triangles (Chit-AgNPs) were used as a photothermal agents against a line of human nonsmall lung cancer cells (NCI-H460) [104]. In another work, AgNPs (10 nm) were synthesized using
Algal-synthesized NPs are explored in certain other area of applications, which include the synthesis of spherical palladium nanocrystals via aqueous Na2 [PdCl4] solution using the photosynthetic reaction within
The use of nanoparticles as antibiofilm agents is an emerging area of research. Due to the extensive use and misuse of antibiotics, many of the pathogens acquired resistance toward multiple drugs. As the bacteria are less likely to develop resistance against nanoparticles, they can be used as a promising therapeutic agent against biofilms. Nanoparticles have the ability to penetrate EPS and the cell membranes (Figure 6). Silver nanoparticles were found to be more prevalent than the other ones, and they exhibit antibiofilm activity against both Gram-positive and Gram-negative pathogens. In a work done by LewisOscar et al. [108]. Chemical synthesis of CuNPs was performed by one-pot synthesized method and used for biofilm inhibition against
Antibiofilm activity of different nanoparticles.
The zero-valent selenium and tellurium NPs synthesized using
The diatom
There are possibilities for the production of lipid nanoparticles with the help of lipid-rich marine organisms such as algae, fungi, and bacteria [138]. Lipid nanoparticles can be synthesized from the organisms through heating to liquefy fatty acids; incorporating active agents of pharmacological and cosmetics importance; adding a hot surfactant; and stirring or homogenized under high pressure by ultrasound. These can be used in the production of food stuffs, cosmetics, and medicines [139].
\nAlgal-synthesized NPs can be explored in biosensing applications. Such as, AuNPs has been proved as an important tool for hormone (HCG) detection in pregnant women urine sample [140]. Platinum (Pt) NPs act as a novel biosensor with high sensitivity for the determination of adrenaline for the treatment of allergies, heart attack, asthma, and cardiac surgery [141]. Synthesis of nanoscale Au–Ag alloy prepared using chloroplasts exhibited high electrocatalytic activity for 2-butanone at room temperature which can be developed as a tool for detecting cancer at early stages [142].
\nThe developing era of nanoscience is a renowned gift for the development of science all over the world. Despite numerous studies conducted over the last decade, there are still considerable gaps in our knowledge about the biotechnological potential of green-synthesized nanoparticles. Furthermore, the precise basis of their antibiotic and antibiofilm activity has yet to be defined. However, the toxicity of nanoparticles to eukaryotic cells is a legitimate concern and still remains uncharacterized. One way of avoiding this potential drawback might be to target green-synthesized nanoparticles to the specific site of an infection so that toxic nanoparticles concentrations are localized. In addition, improvements in the way that green-synthesized nanoparticles are incorporated into medical devices could increase their efficacy and diminish any side effects, but considerable research effort is still required to perfect this technology.
\nFinancial support provided to Dr. C.N by the DST INSPIRE faculty scheme is gratefully acknowledged (DST/Inspire Faculty Award/2012 [IFA12- LSPA13]). The authors gratefully acknowledge DBT [BT/PR7005/PBD26/357/2012 dated: 26.03.2015 and BT/PR6619/PBD/26/310/2012] for their financial assistance, and FIST program provided by the DST-FIST scheme [SR/FST/LSI-523/2012] is gratefully acknowledged.
\nAccording to the Organ Procurement and Transplantation Network, there are currently over 110,000 patients on the waiting list for organ transplants. Over the past 50 years, therapeutic advances and improvements in surgical techniques have increased the number of patients who could survive and benefit from organ transplantation. Unfortunately, the number of organs available through donation has not changed significantly. Thus, there is a growing disparity between organ supply and demand. Although efforts to enlarge the human donor pool have improved organ availability, even a massive expansion in organ donation would not ensure that a compatible organ would be available when and where necessary for a patient in need. Therefore, other alternatives besides expanded human donation are required.
A variety of efforts are making substantial progress in addressing the lack of organs. One area of research that is rapidly approaching clinical reality is xenotransplantation, the use of animal tissues and organs to treat patients [1]. Aside from the potential for creating an unlimited supply of organs, recent advancements in genome engineering technologies allows the genetic modification of animals to produce donor organs which are less prone to rejection for xenotransplantation in human patients.
Xenotransplantation experiments were described as early as the seventeenth-century [2], with sporadic attempts made to transplant a variety of animal tissues and organs into patients throughout the nineteenth and early twentieth centuries [3, 4, 5, 6, 7]. After World War II, organ transplantation from living humans was considered too high risk, and cadaveric organs were insufficient in both quality and number to meet clinical needs. Development of immunosuppressive drugs suggested the possibility that organs from more closely-related mammals could potentially be used in humans. As a consequence, xenotransplantation efforts shifted to the use of organs from primates in human patients. In the 1960s, experiments by Reemstma et al. [8, 9], Hardy et al. [10], and Starzl et al. [11, 12] showed that while it was technically possible to transplant animal organs into humans, there were still too many clinical challenges at that time for the approach to be viable. More research was required to understand and overcome the barriers to the practical application of xenotransplantation in humans.
One of the major advances in xenotransplantation research in the past few decades has been the focus on the use of pigs as donors [13]. This was based, in part, on purely practical considerations. Unlike primates, pigs are an agricultural species for which large scale breeding is well-established. In addition, the evolutionary distance between humans and pigs reduces the risk of transmission of zoonoses from pig organs to patients compared with primate organs. Most importantly, the use of porcine organs does not present the same ethical barriers as the use of non-human primate organs [14].
Although the anatomy and physiology of pig organs is closely analogous to that of humans, the advantages of porcine organ production and availability do not address the critical issue of incompatibilities of non-human tissues and organs with the human immune system [15]. Significant advancements have been made in recent years in understanding the molecular mechanisms of xenorejection responses, and a variety of genetic modifications have been made to overcome these mechanisms. Experiments transplanting pig organs into non-human primates have demonstrated a progressive improvement in organ survival and function as new genetics and drug regimens have been implemented [16]. The FDA is currently developing guidelines for clinical xenotransplantation [17], and efforts to initiate clinical trials in the near term have been announced [18].
The immune system is designed to recognize and eliminate harmful pathogens, while remaining unresponsive to host cells and beneficial microbes. The immune system can be divided into innate and adaptive responses, an interdependent set of activities which both contribute to immunity. The innate response is more immediate, broadly recognizing conserved microbial elements, such as cell wall polysaccharides, and activating a variety of cell types which attack the invading pathogens [19]. The adaptive immune response, which is typically initiated by innate response mechanisms, leads to more precise antigen-specific antibodies and immune cells that continue to control and eliminate pathogens. In addition, the adaptive response creates long-lasting immune “memory” for rapid and specific protection against future infections, as demonstrated by vaccines [20].
Despite being described as separate systems, the innate and adaptive immune responses are highly interdependent and create a layered set of defenses with increasing specificity for pathogens over time [21]. Under normal circumstances, any individual function may not eliminate a given target with 100% efficiency, but when used together in a redundant fashion can prevent nearly all infection. Although the specificity of the immune response indirectly helps to avoid recognition of host tissues, additional tolerance mechanisms are required to restrain the immune system to prevent autoreactivity. Disruptions of the balance between immunity and tolerance can lead to the immune system destroying host tissues (autoimmunity) or allowing repeated severe infections (immunodeficiency) [22].
The transplantation of foreign cells or tissues into a human host can trigger a hostile response from the immune system, leading to immune rejection. The extraordinary precision of the immune system can distinguish even minor differences between donor and recipient, so that even organs from closely related donors may be rejected. Although immunosuppressive drugs can reduce the chance of rejection of human donor organs, the massive amount of immunogenic material found in a whole organ presents an ongoing risk which requires monitoring. Because of the greater genetic differences between pigs and humans, the vigor of the rejection response is much stronger than occurs between human donors and recipients, requiring more and different solutions.
A major advantage in using pigs for xenotransplantation is the potential to manipulate the porcine genome to create donor organs that are more compatible for human patients. However, the scope of the engineering challenge in xenotransplantation is extremely large, involving a variety of genes and pathways. With so many potential targets for genetic modification, an assortment of different genome engineering strategies have been applied, including editing or deletion of porcine genes and insertion of human or engineered genes. Because of the great diversity of genome modification efforts being carried out in xenotransplantation research, representative approaches will be highlighted here as examples of the general types of the engineering strategies being employed.
Historically, mice have been subject to more and different genetic modifications than any other mammalian species, and many of the protocols described here were first developed in mice. Aside from their well-established and convenient husbandry, small size, and rapid generation times, mice also have a variety of technological advantages for genome manipulation and production. Although genetic modification has been demonstrated for multiple agricultural species, including pigs, the scale and complexity possible with mice has, until recently, not been available for pigs [23].
One advantage for the creation of mice with multiple genetic modifications is the availability of embryonic stem (ES) cells, which can be cultured
Mouse ES cells not only allow more straightforward and efficient genome engineering, but also facilitate large scale production of cloned mice. The mouse ES cells typically employed for genetic modification can be injected into very early stage embryos (blastocysts) and will aggressively populate the inner cell mass, creating viable chimeric mice which are almost entirely ES-cell derived. Since the ES cells will also contribute to the germ cells of the chimeric mice, the progeny will be highly likely to receive the genetic modifications made to the ES cells [27]. Without readily available porcine ES cells, pig cloning instead relies upon somatic cell nuclear transfer (SCNT), similar to the protocols used to create the sheep “Dolly”. In this approach, pig oocyte nuclei are replaced with nuclei from the modified primary pig cells, and embryonic development stimulated electrochemically. The embryos are transferred to female surrogates and allowed to develop. The level of complexity and effort involved leads to lower efficiencies and higher costs for porcine SCNT relative to mouse ES cell cloning. Additionally, the size and scale of the facilities required for pig cloning is significantly greater compared with mouse cloning, further limiting availability [28].
In the following sections, different types of gene modifications are described with examples of their application in porcine genome engineering for xenotransplantation.
As mentioned above, porcine cells produce molecules which are rapidly recognized by the human immune system and rejected. One straightforward approach to engineering the pig would be to simply eliminate the genes encoding reactive genes by either disrupting or removing the coding sequence. Several of the technical routes which can be employed to accomplish this are discussed below.
Gene knockout (KO) approaches developed for use in mouse ES cells generally rely upon homologous recombination to replace a region of genomic DNA with a heterologous DNA sequence, which interrupts the function of the target gene [29]. To accomplish this, a DNA vector is generated with the heterologous DNA flanked on either side by sequences identical to regions flanking the genomic region to be eliminated. When introduced into mouse ES cells, the flanking sequences of the DNA vector first align with the cognate regions of the genome on either side of the target gene, after which the homologous recombination machinery replaces the genomic target with the heterologous DNA vector sequence found between the flanking sequences.
Because homologous recombination occurs at a relatively low rate, in order to identify properly targeted cells within the larger cell population, it is common to include a gene in the heterologous DNA to be inserted into the genome, which, once properly inserted, allows selection of the desired cells. For example, genes which confer resistance to drugs which kill mammalian cells (neomycin hygromycin or puromycin resistance), or genes encoding molecules that enable cells to be isolated via flow cytometry (green fluorescent protein or novel cell surface markers), allow isolation of even extremely rare targeted cells from a large mixed population [30].
The use of gene KO approaches was one of the earliest successes in pig genetic modification for xenotransplantation [31]. The porcine genome encodes proteins that can be substantially different from their human counterparts, or that carry additional modifications which are not present in humans and can induce immune responses. These molecules are collectively referred to as “xenoantigens” [32]. Some of the most reactive of these targets are carbohydrate molecules found as post-translational modifications to proteins observed in pig, but not human, cells. Human serum can contain high levels of pre-existing antibodies specific for these porcine-specific glycan epitopes, leading to the destruction of pig cells expressing these molecules through antibody-dependent cell-mediated cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC) mechanisms [33]. It is not entirely clear why human serum carries antibodies to these particular carbohydrates; one proposal is that the xenoantigens are related to glycans found in the cell walls of pathogens, others suggest that the human dietary consumption of pork causes antibody generation to the porcine-specific molecules [34]. Because the novel carbohydrate structures are created by specific glycosylation enzymes, it is possible to eliminate the gene responsible for the enzymatic activity and prevent the xenoantigen from being expressed by pig cells.
The GGTA1 gene encodes the enzyme responsible for creating the highly reactive glycan Gal alpha (1,3) Gal epitope in pigs [35]. The KO of the GGTA1 gene is one of the earliest genetic modifications of pigs for application in xenotransplantation, and resulted in greatly reduced human antibody recognition of porcine cells [36, 37]. However, ablation of the GGTA1 gene alone did not completely eliminate porcine cell recognition by human serum antibodies. The enzymes responsible for other xenoantigens, such as CMAH (cytidine monophosphate-N-acetylneuraminic acid hydroxylase critical for Neu5Gc biosynthesis) and B4GALNT2 (beta 1,4 N-acetylgalactosaminyltransferase), have been identified as sources of porcine-specific epitopes bound by antibodies found in human serum. In each case, the deletion of the gene responsible for creating the specific glycan leads to greatly decreased recognition of porcine cells by antibodies in human serum, and reduction in complement-mediated destruction [38, 39].
Another subset of xenoantigens is the swine leukocyte antigens (SLA), the physical and functional equivalent of the human leukocyte antigens (HLA) [40]. Much like the case for human HLA, the SLA genes are highly diverse and individual patients will have a variable level of cross-reactive antibodies in their serum for a given set of SLA genes [41]. Although typing of patients and porcine donors to find the best HLA-SLA matches would be similar to the current system used for determining allotransplant cross-reactivity [42], use of gene targeting or editing technologies could easily eliminate the genes encoding SLA entirely. However, unlike the glycan epitopes described above, the SLA have a critical role in antigen presentation as part of the immune response, and thus the deletion of SLA could create risks of immune deficiencies that outweigh their risks as xenoantigens. Instead, alternate approaches seek to create engineered SLA proteins lacking the epitopes responsible for the immunogenicity while maintaining their antigen presentation functions [43].
The ease and efficiency of creating gene KO has improved recently through the use of engineered molecules to create genome disruptions in a process referred to as “gene editing”. These novel molecules can be designed to generate double-strand DNA breaks at virtually any chosen genomic site
The most prominent of these novel tools for gene editing are Zinc Finger Nucleases (ZFN), Transcription Activator-Like Effector Nuclease (TALEN) and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), each of which consists of two regions: a sequence-specific DNA binding domain and an enzymatic function that creates a double-strand break in the target DNA [45, 46, 47]. For ZFN and TALEN, the synthetic DNA binding domain is created by repetitive protein modules which can be joined combinatorially to recognize a particular DNA sequence. Both approaches, while successful, require a significant investment of time and resources to identify functional molecules. CRISPR, like ZFN and TALEN, has the ability to generate double-strand DNA breaks, however, the DNA binding domain relies upon RNA base-pairing with target DNA for its precision. The use of an RNA to guide specificity greatly improves the speed and efficiency in identifying optimal molecules at a much lower cost, which has led to its rapid adoption in genome engineering [48, 49].
The use of CRISPR for the rapid modification of the pig genome was recently demonstrated with the ablation of porcine endogenous retroviral (PERV) sequences. The pig genome carries 25 or more copies of these gamma retroviral sequences, which are transmitted from parent to offspring through inheritance. Application of CRISPR was able to eliminate the PERV sequences from the genome of porcine cells [50]. Although the potential risk of infectious disease from porcine organs caused by PERV sequences in xenotransplantation is debatable, the results show the ability of CRISPR to target multiple, homologous loci throughout the genome. A key question that has arisen regarding large scale CRISPR targeting at multiple genomic sites is whether significant numbers of off-target double-stranded breaks were introduced, which may create unexpected mutations in the resulting pigs [51]. Nonetheless, the ease of use of CRISPR has resulted in widespread adoption for genome engineering in xenotransplantation.
Gene deletion has been instrumental in the advancement of xenotransplantation, however, there are limitations to its application; the genes of interest must be non-essential to pig viability, development, fertility and, most importantly, organ function. The number of distinct loci to be targeted is also a serious consideration, since independently-assorting alleles will be challenging to breed together in a reasonable timeframe. To address these concerns, additional engineering strategies are required as discussed below.
Gene KO and editing techniques have been used for ablation of xenoantigen genes but do not address the need to express human or synthetic genes in pig cells and organs. Unlike gene deletions, gene insertions require heterologous DNA to be introduced into the genome in a manner that allows subsequent expression of the gene(s) encoded by the inserted DNA. Because they are being transferred into the genome from another source, these novel genes are referred to as “transgenes” (TG), whether they are derived from natural or synthetic sequences. The general approaches to introduce TG into the genome are detailed below.
One of the earliest types of genetic modification described in mammals was insertion of DNA into the target genome by random integration. After transfection of DNA into nearly all mammalian cells, some portion of the heterologous DNA can be found incorporated at random sites in the genome [52]. The precise process for this is unclear, but presumably is a result of aberrant repair mechanisms. One hypothesis is that endogenous NHEJ machinery recognizes breaks in the genome and fortuitously utilizes the relatively higher concentration of the heterologous DNA vector sequences to repair the break [53], resulting in the insertion of the TG into the genome.
Agricultural species, including pig, were some of the earliest TG animals described, establishing the utility of this approach [54]. For xenotransplantation, several of the initial TG approaches focused on inhibiting human antibody-mediated damage of porcine organs. The binding of human antibodies to porcine cells leads to complement pathway activation and subsequent cell ablation [55]. The complement function is controlled by several proteins, such as CD46, CD55 and CD59, referred to as complement regulatory proteins (CRPs). The CRPs are broadly expressed on many different cell types to prevent harm from complement activity by raising the threshold of antibody binding required for complement pathway induction [56]. The transgenic expression of human CRPs in pigs appears to overcome human complement activity, and may have the potential to reduce, or even eliminate, the need for xenoantigen KOs. By placing the human CRP TGs under the control of strong gene expression elements, the CRP protein levels on the porcine cells can be much higher than CRP levels on normal human cells, further increasing resistance to complement-mediated destruction [57].
Pig lineages developed by multiple labs have been engineered to express human CRPs, individually or in combination. In most cases, the porcine cells appeared to be more resistant to complement-mediated destruction, and organs from TG animals survived longer in xenotransplant experiments in non-human primates [58, 59, 60]. Because each of the CRPs control a different part of the complement pathway, the use of multiple human TGs was more effective in protecting cells from complement-mediated destruction than individual TGs [61]. Together with the removal of key xenoantigens, the expression of human CRPs by porcine cells has greatly reduced the effects of human serum antibodies on xenografts.
Because random insertion of DNA does not require homologous recombination, it is relatively rapid and efficient to produce transgenic animals [62]. The process is so efficient that the selection methods that are critical for gene KO described above are often unnecessary for TG. Despite the speed and ease of generation, random integration of TGs has several drawbacks. Variabilities in genome structure can affect the expression level of genes inserted at distinct chromosomal regions, such that identical TGs may express at very different levels depending upon their specific location [63]. Furthermore, multiple copies of a given TG may be inserted into the genome at a single site, creating concatenated repeats which can be unstable and yield variable expression levels [64]. Random TG insertion may occur within or near endogenous genes and alter or inactivate their function, leading to tumorigenesis, instability or even lethality [65].
The development of techniques for precise gene KO by homologous recombination has been adapted for site-specific gene insertion or gene knock-in (KI). Similar to the KO vectors described above, the gene to be introduced is flanked by DNA sequences that are identical to regions of the genome to be targeted. After introduction of the heterologous DNA vector, the regions of DNA sequence identity are aligned with the target genome sequence, after which the homologous recombination machinery catalyzes reactions which swap the endogenous genomic DNA with the heterologous DNA within the construct. If the recombination event occurs with high fidelity, the gene of interest will functionally replace the gene that was removed [24]. Similar to gene KO, this approach is much less efficient than random TG integration. Therefore, vectors carrying the TG are often designed to incorporate selectable markers, similar to those used for gene KO, to allow the identification of cells carrying the desired TG in the genome. In this case, both targeted and randomly integrated TGs may be selected, requiring additional assays, such as PCR or Southern blotting, to distinguish between sequence-specific and random insertion events [30].
As described above for gene KO, specific targeting is more efficient in murine ES cells, which express the enzymatic machinery necessary for homologous recombination, than is currently possible for pig primary cells. Insertion of heterologous DNA into the mammalian genome is believed to be driven by endogenous DNA repair mechanisms, presumably in response to DNA breaks, whether randomly via NHEJ, or specifically via homologous recombination [66]. The deliberate introduction of double-stranded DNA breaks at the desired integration site should therefore improve the efficiency of heterologous DNA insertion by activating and recruiting the cellular repair machinery. Application of ZFN, TALEN and CRISPR technologies have shown that homologous recombination efficiencies are improved when one or more double-strand DNA breaks are introduced into the genome at the desired site of insertion [67] with CRISPR exhibiting bi-allelic targeting rates as high as 90% [68]. The use of these more advanced genome engineering tools has greatly improved the rates and specificity of both gene deletion and gene insertion in genomes.
Gene insertion by homologous recombination for xenotransplantation has not advanced as rapidly as other approaches, in part due to the challenges of using primary porcine cells, for which the efficiencies can be extremely low, particularly with large DNA constructs. Use of improved genome engineering tools with increased targeting efficiencies have already been applied in pig and will continue to grow in impact [69]. However, even with improved efficiencies of gene insertion, breeding pigs with multiple, independently segregating loci is challenging. The number of litters required to produce animals bearing all of the genetic modifications greatly increases with each additional locus, which can be impractical for large animals such as pigs. Therefore, the ability to insert the maximal amount of genetic information into the genome in the minimal number of steps, as discussed below, is highly valuable.
The most straightforward example of multigenic targeting at a single site takes advantage of the observation that multiple DNA vectors co-transfected into cells will tend to insert together at a given genome site. This approach was used successfully to simultaneously introduce as many as five large transgenes in a single step into porcine cells [70]. Although difficulties in producing mature cloned pigs limited the study to animals with fewer integrated genes, the study demonstrated the feasibility of rapidly making animals with multiple TG.
Another, relatively less complicated, way to introduce multiple TG is to generate large DNA constructs bearing multiple TGs for integration at random into the genome [71]. This greatly reduces the complexity of screening, while increasing the efficiency of insertion, but still relies upon random integrants which can have variable TG copy numbers and expression levels.
Multiple genomic regions have been defined, such as Rosa26, which allow expression of heterologous genes at similar levels regardless of cell type. These “safe harbor” regions are believed to have a chromatin structure that is more easily accessible to the gene expression machinery, regardless of cell type. Targeting at porcine homologs of murine safe harbor sites such as Rosa26 has been described and demonstrates the utility of this approach [70, 72]. On a practical level, the use of safe harbor sites yields more reproducible gene expression than random TG insertions, so fewer lineages are required to select animals with desired TG levels. Furthermore, the defined location and copy number of TG inserted at a safe harbor site makes breeding and genotyping more straightforward, and is expected to provide a less complicated regulatory pathway for clinical use.
As DNA synthesis and assembly has improved, increasingly large DNA constructs encoding a variety of TG are possible, however, as the size of the DNA increases, the rate of insertion decreases. Considering the lower insertion rates observed for large animals such as pig, alternate approaches are necessary to incorporate larger DNAs into the genome.
Bacteriophage- and yeast-derived site-specific recombinases are, as the name suggests, proteins which catalyze recombination between two specific DNA recognition sites, small (<50 base pair) sequences that are unique to the recombinase being used. The recombination event is highly efficient, in some cases eliminating the need for selection genes, and allowing large DNA constructs to be inserted at a much higher frequency than possible for homologous recombination [73].
One limitation for the use of site-specific recombination is the need for a recognition sequence to be present in the target genome at the desired locus. This requires a preceding step in which the recognition site is engineered into the genome using less efficient homologous recombination. Therefore, the gain in efficiency for introduction of large DNA constructs may be offset by the need for insertion of the recombinase recognition site into the genome. Despite this constraint, the potential for site-specific recombination into a defined locus has been demonstrated in pigs [70] and provides a route for more rapid complex genetic modifications.
The advancements in genome engineering, both in general and in their application to xenotransplantation, have been significant, but many needs remain to be addressed. As new genome engineering tools are identified and further refined, improvement of targeting efficiencies will allow more sophisticated modifications of the pig genome. Ideally, the pig genome will become as readily manipulated as the mouse, allowing researchers to further leverage approaches shown to be effective in murine models.
One major technological difference in the genetic modification of mice and pigs (and many other mammalian species) is the lack of ES cells possessing significant rates of homologous recombination that can be grown in culture for extended periods and subjected to multiple manipulations without losing the ability to produce viable pigs. Efforts to identify natural or induced pluripotent stem cells (iPSC) suitable for these purposes have been described, but have yet to demonstrate practical application for porcine genome engineering [74]. Ongoing work will be required to identify and validate cells which meet these needs.
The function of the TGs themselves can also be further improved. The majority of TG constructs used in pigs have used constitutive promoters to drive high level expression of the proteins encoded by the TGs. In some cases, such as CRPs, this approach may be useful, however, overexpression of TGs which inhibit critical immune processes may create risks of immune deficiency and infections. For this reason, use of expression control elements which can turn on and off TG activity is of increasing interest in xenotransplantation. There are multiple examples of inducible promoters employed in mice which can be controlled by exogenously applied small molecules (such as the tetracycline repressor system), or by endogenous signals (such as promoters for innate immune response genes) [75]. Advanced DNA synthesis and assembly methods also allow synthetic biology approaches to create novel signaling pathways and networks not present in nature.
Immune tolerance is another very active area in xenotransplantation research. As the molecular mechanisms controlling the balance between immunity and tolerance are further elucidated, manipulation of the human immune system itself to specifically reduce or eliminate responses to porcine targets, while leaving intact immunity to infectious diseases, will help overcome xenorejection. Multiple approaches are currently being tested and genome targets identified to encourage human immune tolerance of porcine cells and tissues [76, 77].
The speed and ease of genome engineering technologies has helped to overcome many of the limitations for the use of pig organs for xenotransplantation. Despite recent achievements, a key question remains: which combination of genetic modifications is most critical to make a pig organ useful for xenotransplantation? Ongoing experiments seek to address this question, but the answers are likely to be complex and dependent upon the type of organ, the specific immune mechanisms involved, and perhaps other factors that are not yet defined. It is very likely that the first set of genetic modifications of pigs used for xenotransplantation in humans will not be the final set, as the understanding of the mechanisms of xenorejection increases and better strategies developed to influence the human immune response. Continuing progress in genome engineering technologies of pigs will allow the creation of the more complex modifications necessary to meet these demands. Although much remains to be done, it is clear that given the current rate of progress, overcoming the crisis of human organ shortage with unlimited rejection-free porcine organs is rapidly growing closer to reality.
IntechOpen will act in accordance with its published Refund Policy if requests for refunds are made.
",metaTitle:"Refund Policy",metaDescription:"IntechOpen will act in accordance with its Refund Policy if requests for refunds are made.",metaKeywords:null,canonicalURL:"/page/refund-policy",contentRaw:'[{"type":"htmlEditorComponent","content":"Refunds are possible in the following cases:
\\n\\n1. A double payment, in which case a full refund will be made.
\\n\\n2. A justified withdrawal of work by the Author, which had already been accepted during or after production but prior to publication. In this situation, a 50% refund will be made. (IntechOpen reserves the right to determine, at its discretion, whether withdrawal is justified and, consequently, whether a refund should be issued).
\\n\\n3. In those rare instances where IntechOpen declines to publish a book that had been previously accepted, full refunds will be made to the same account or credit card from which the Author made the original payment.
\\n\\nPlease note that refunded amounts will not always be exactly the same as original payment amounts due to bank transaction fees and expenses. Any such costs will be split evenly between IntechOpen and the Author.
\\n"}]'},components:[{type:"htmlEditorComponent",content:"Refunds are possible in the following cases:
\n\n1. A double payment, in which case a full refund will be made.
\n\n2. A justified withdrawal of work by the Author, which had already been accepted during or after production but prior to publication. In this situation, a 50% refund will be made. (IntechOpen reserves the right to determine, at its discretion, whether withdrawal is justified and, consequently, whether a refund should be issued).
\n\n3. In those rare instances where IntechOpen declines to publish a book that had been previously accepted, full refunds will be made to the same account or credit card from which the Author made the original payment.
\n\nPlease note that refunded amounts will not always be exactly the same as original payment amounts due to bank transaction fees and expenses. Any such costs will be split evenly between IntechOpen and the Author.
\n"}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/55578/images/4574_n.png",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:5828},{group:"region",caption:"Middle and South America",value:2,count:5289},{group:"region",caption:"Africa",value:3,count:1765},{group:"region",caption:"Asia",value:4,count:10555},{group:"region",caption:"Australia and Oceania",value:5,count:909},{group:"region",caption:"Europe",value:6,count:15952}],offset:12,limit:12,total:119464},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{sort:"dateEndThirdStepPublish",topicId:"20"},books:[{type:"book",id:"10956",title:"Pulsed Lasers",subtitle:null,isOpenForSubmission:!0,hash:"88bd906b149fc3d1c5d6fdbd9916826c",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10956.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10672",title:"Nonlinear Optics",subtitle:null,isOpenForSubmission:!0,hash:"cfe87b713a8bee22c19361b86b03d506",slug:null,bookSignature:"Dr. Boris I. Lembrikov",coverURL:"https://cdn.intechopen.com/books/images_new/10672.jpg",editedByType:null,editors:[{id:"2359",title:"Dr.",name:"Boris",surname:"Lembrikov",slug:"boris-lembrikov",fullName:"Boris Lembrikov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10674",title:"Topics on Quantum Information Science",subtitle:null,isOpenForSubmission:!0,hash:"d7481712cff0157cd8f849cba865727d",slug:null,bookSignature:"Prof. Sergio Curilef and Dr. Angel Ricardo Plastino",coverURL:"https://cdn.intechopen.com/books/images_new/10674.jpg",editedByType:null,editors:[{id:"125424",title:"Prof.",name:"Sergio",surname:"Curilef",slug:"sergio-curilef",fullName:"Sergio Curilef"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10921",title:"Plasma Science and Technology",subtitle:null,isOpenForSubmission:!0,hash:"c45670ef4b081fd9eebaf911b2b4627b",slug:null,bookSignature:"Dr. Aamir Shahzad",coverURL:"https://cdn.intechopen.com/books/images_new/10921.jpg",editedByType:null,editors:[{id:"288354",title:"Dr.",name:"Aamir",surname:"Shahzad",slug:"aamir-shahzad",fullName:"Aamir Shahzad"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10852",title:"Electromagnetic Compatibility",subtitle:null,isOpenForSubmission:!0,hash:"f5d2cce3a2adbd5d108d3301ee97025b",slug:null,bookSignature:"Dr. Ahmed Kishk",coverURL:"https://cdn.intechopen.com/books/images_new/10852.jpg",editedByType:null,editors:[{id:"150146",title:"Dr.",name:"Ahmed",surname:"Kishk",slug:"ahmed-kishk",fullName:"Ahmed Kishk"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:29},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:8},{group:"topic",caption:"Business, Management and Economics",value:7,count:4},{group:"topic",caption:"Chemistry",value:8,count:9},{group:"topic",caption:"Computer and Information Science",value:9,count:10},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:10},{group:"topic",caption:"Engineering",value:11,count:29},{group:"topic",caption:"Environmental Sciences",value:12,count:4},{group:"topic",caption:"Immunology and Microbiology",value:13,count:4},{group:"topic",caption:"Materials Science",value:14,count:7},{group:"topic",caption:"Mathematics",value:15,count:3},{group:"topic",caption:"Medicine",value:16,count:51},{group:"topic",caption:"Neuroscience",value:18,count:3},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:3},{group:"topic",caption:"Physics",value:20,count:4},{group:"topic",caption:"Psychology",value:21,count:4},{group:"topic",caption:"Robotics",value:22,count:2},{group:"topic",caption:"Social Sciences",value:23,count:4},{group:"topic",caption:"Technology",value:24,count:1},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:2}],offset:12,limit:12,total:5},popularBooks:{featuredBooks:[{type:"book",id:"9893",title:"Automation and Control",subtitle:null,isOpenForSubmission:!1,hash:"09ba24f6ac88af7f0aaff3029714ae48",slug:"automation-and-control",bookSignature:"Constantin Voloşencu, Serdar Küçük, José Guerrero and Oscar Valero",coverURL:"https://cdn.intechopen.com/books/images_new/9893.jpg",editors:[{id:"1063",title:"Prof.",name:"Constantin",middleName:null,surname:"Volosencu",slug:"constantin-volosencu",fullName:"Constantin Volosencu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7016",title:"Cardiovascular Risk Factors in Pathology",subtitle:null,isOpenForSubmission:!1,hash:"7937d2c640c7515de372282c72ee5635",slug:"cardiovascular-risk-factors-in-pathology",bookSignature:"Alaeddin Abukabda, Maria Suciu and Minodora Andor",coverURL:"https://cdn.intechopen.com/books/images_new/7016.jpg",editors:[{id:"307873",title:"Ph.D.",name:"Alaeddin",middleName:null,surname:"Abukabda",slug:"alaeddin-abukabda",fullName:"Alaeddin Abukabda"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9873",title:"Strategies of Sustainable Solid Waste Management",subtitle:null,isOpenForSubmission:!1,hash:"59b5ceeeedaf7449a30629923569388c",slug:"strategies-of-sustainable-solid-waste-management",bookSignature:"Hosam M. Saleh",coverURL:"https://cdn.intechopen.com/books/images_new/9873.jpg",editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:"M.",surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9154",title:"Spinal Deformities in Adolescents, Adults and Older Adults",subtitle:null,isOpenForSubmission:!1,hash:"313f1dffa803b60a14ff1e6966e93d91",slug:"spinal-deformities-in-adolescents-adults-and-older-adults",bookSignature:"Josette Bettany-Saltikov and Gokulakannan Kandasamy",coverURL:"https://cdn.intechopen.com/books/images_new/9154.jpg",editors:[{id:"94802",title:"Dr.",name:"Josette",middleName:null,surname:"Bettany-Saltikov",slug:"josette-bettany-saltikov",fullName:"Josette Bettany-Saltikov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10405",title:"River Basin Management",subtitle:"Sustainability Issues and Planning Strategies",isOpenForSubmission:!1,hash:"5e5ddd0f2eda107ce19c4c06a55a8351",slug:"river-basin-management-sustainability-issues-and-planning-strategies",bookSignature:"José Simão Antunes Do Carmo",coverURL:"https://cdn.intechopen.com/books/images_new/10405.jpg",editors:[{id:"67904",title:"Prof.",name:"José Simão",middleName:null,surname:"Antunes Do Carmo",slug:"jose-simao-antunes-do-carmo",fullName:"José Simão Antunes Do Carmo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7030",title:"Satellite Systems",subtitle:"Design, Modeling, Simulation and Analysis",isOpenForSubmission:!1,hash:"b9db6d2645ef248ceb1b33ea75f38e88",slug:"satellite-systems-design-modeling-simulation-and-analysis",bookSignature:"Tien Nguyen",coverURL:"https://cdn.intechopen.com/books/images_new/7030.jpg",editors:[{id:"210657",title:"Dr.",name:"Tien M.",middleName:"Manh",surname:"Nguyen",slug:"tien-m.-nguyen",fullName:"Tien M. Nguyen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8472",title:"Bioactive Compounds in Nutraceutical and Functional Food for Good Human Health",subtitle:null,isOpenForSubmission:!1,hash:"8855452919b8495810ef8e88641feb20",slug:"bioactive-compounds-in-nutraceutical-and-functional-food-for-good-human-health",bookSignature:"Kavita Sharma, Kanchan Mishra, Kula Kamal Senapati and Corina Danciu",coverURL:"https://cdn.intechopen.com/books/images_new/8472.jpg",editors:[{id:"197731",title:"Dr.",name:"Kavita",middleName:null,surname:"Sharma",slug:"kavita-sharma",fullName:"Kavita Sharma"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10201",title:"Post-Transition Metals",subtitle:null,isOpenForSubmission:!1,hash:"cc7f53ff5269916e3ce29f65a51a87ae",slug:"post-transition-metals",bookSignature:"Mohammed Muzibur Rahman, Abdullah Mohammed Asiri, Anish Khan, Inamuddin and Thamer Tabbakh",coverURL:"https://cdn.intechopen.com/books/images_new/10201.jpg",editors:[{id:"24438",title:"Prof.",name:"Mohammed Muzibur",middleName:null,surname:"Rahman",slug:"mohammed-muzibur-rahman",fullName:"Mohammed Muzibur Rahman"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10413",title:"A Collection of Papers on Chaos Theory and Its Applications",subtitle:null,isOpenForSubmission:!1,hash:"900b71b164948830fec3d6254b7881f7",slug:"a-collection-of-papers-on-chaos-theory-and-its-applications",bookSignature:"Paul Bracken and Dimo I. Uzunov",coverURL:"https://cdn.intechopen.com/books/images_new/10413.jpg",editors:[{id:"92883",title:"Prof.",name:"Paul",middleName:null,surname:"Bracken",slug:"paul-bracken",fullName:"Paul Bracken"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9515",title:"Update in Geriatrics",subtitle:null,isOpenForSubmission:!1,hash:"913e16c0ae977474b283bbd4269564c8",slug:"update-in-geriatrics",bookSignature:"Somchai Amornyotin",coverURL:"https://cdn.intechopen.com/books/images_new/9515.jpg",editors:[{id:"185484",title:"Prof.",name:"Somchai",middleName:null,surname:"Amornyotin",slug:"somchai-amornyotin",fullName:"Somchai Amornyotin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8148",title:"Investment Strategies in Emerging New Trends in Finance",subtitle:null,isOpenForSubmission:!1,hash:"3b714d96a68d2acdfbd7b50aba6504ca",slug:"investment-strategies-in-emerging-new-trends-in-finance",bookSignature:"Reza Gharoie Ahangar and Asma Salman",coverURL:"https://cdn.intechopen.com/books/images_new/8148.jpg",editors:[{id:"91081",title:"Dr.",name:"Reza",middleName:null,surname:"Gharoie Ahangar",slug:"reza-gharoie-ahangar",fullName:"Reza Gharoie Ahangar"}],equalEditorOne:{id:"206443",title:"Prof.",name:"Asma",middleName:null,surname:"Salman",slug:"asma-salman",fullName:"Asma Salman",profilePictureURL:"https://mts.intechopen.com/storage/users/206443/images/system/206443.png",biography:"Professor Asma Salman is a blockchain developer and Professor of Finance at the American University in the Emirates, UAE. An Honorary Global Advisor at the Global Academy of Finance and Management, USA, she completed her MBA in Finance and Accounting and earned a Ph.D. in Finance from an AACSB member, AMBA accredited, School of Management at Harbin Institute of Technology, China. Her research credentials include a one-year residency at the Brunel Business School, Brunel University, UK. Prof. Salman also served as the Dubai Cohort supervisor for DBA students under the Nottingham Business School, UK, for seven years and is currently a Ph.D. supervisor at the University of Northampton, UK, where she is a visiting fellow. She also served on the Board of Etihad Airlines during 2019–2020. One of her recent articles on “Bitcoin and Blockchain” gained wide visibility and she is an active speaker on Fintech, blockchain, and crypto events around the GCC. She holds various professional certifications including Chartered Fintech Professional (USA), Certified Financial Manager (USA), Women in Leadership and Management in Higher Education, (UK), and Taxation GCC VAT Compliance, (UK). She recently won an award for “Blockchain Trainer of the Year” from Berkeley Middle East. Other recognitions include the Women Leadership Impact Award by H.E First Lady of Armenia, Research Excellence Award, and the Global Inspirational Women Leadership Award by H.H Sheikh Juma Bin Maktoum Juma Al Maktoum.",institutionString:"American University in the Emirates",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"2",institution:{name:"American University in the Emirates",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"2160",title:"MATLAB",subtitle:"A Fundamental Tool for Scientific Computing and Engineering Applications - Volume 1",isOpenForSubmission:!1,hash:"dd9c658341fbd264ed4f8d9e6aa8ca29",slug:"matlab-a-fundamental-tool-for-scientific-computing-and-engineering-applications-volume-1",bookSignature:"Vasilios N. Katsikis",coverURL:"https://cdn.intechopen.com/books/images_new/2160.jpg",editors:[{id:"12289",title:"Prof.",name:"Vasilios",middleName:"N.",surname:"Katsikis",slug:"vasilios-katsikis",fullName:"Vasilios Katsikis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:5334},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"9893",title:"Automation and Control",subtitle:null,isOpenForSubmission:!1,hash:"09ba24f6ac88af7f0aaff3029714ae48",slug:"automation-and-control",bookSignature:"Constantin Voloşencu, Serdar Küçük, José Guerrero and Oscar Valero",coverURL:"https://cdn.intechopen.com/books/images_new/9893.jpg",editors:[{id:"1063",title:"Prof.",name:"Constantin",middleName:null,surname:"Volosencu",slug:"constantin-volosencu",fullName:"Constantin Volosencu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7016",title:"Cardiovascular Risk Factors in Pathology",subtitle:null,isOpenForSubmission:!1,hash:"7937d2c640c7515de372282c72ee5635",slug:"cardiovascular-risk-factors-in-pathology",bookSignature:"Alaeddin Abukabda, Maria Suciu and Minodora Andor",coverURL:"https://cdn.intechopen.com/books/images_new/7016.jpg",editors:[{id:"307873",title:"Ph.D.",name:"Alaeddin",middleName:null,surname:"Abukabda",slug:"alaeddin-abukabda",fullName:"Alaeddin Abukabda"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9873",title:"Strategies of Sustainable Solid Waste Management",subtitle:null,isOpenForSubmission:!1,hash:"59b5ceeeedaf7449a30629923569388c",slug:"strategies-of-sustainable-solid-waste-management",bookSignature:"Hosam M. Saleh",coverURL:"https://cdn.intechopen.com/books/images_new/9873.jpg",editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:"M.",surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9154",title:"Spinal Deformities in Adolescents, Adults and Older Adults",subtitle:null,isOpenForSubmission:!1,hash:"313f1dffa803b60a14ff1e6966e93d91",slug:"spinal-deformities-in-adolescents-adults-and-older-adults",bookSignature:"Josette Bettany-Saltikov and Gokulakannan Kandasamy",coverURL:"https://cdn.intechopen.com/books/images_new/9154.jpg",editors:[{id:"94802",title:"Dr.",name:"Josette",middleName:null,surname:"Bettany-Saltikov",slug:"josette-bettany-saltikov",fullName:"Josette Bettany-Saltikov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10405",title:"River Basin Management",subtitle:"Sustainability Issues and Planning Strategies",isOpenForSubmission:!1,hash:"5e5ddd0f2eda107ce19c4c06a55a8351",slug:"river-basin-management-sustainability-issues-and-planning-strategies",bookSignature:"José Simão Antunes Do Carmo",coverURL:"https://cdn.intechopen.com/books/images_new/10405.jpg",editors:[{id:"67904",title:"Prof.",name:"José Simão",middleName:null,surname:"Antunes Do Carmo",slug:"jose-simao-antunes-do-carmo",fullName:"José Simão Antunes Do Carmo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7030",title:"Satellite Systems",subtitle:"Design, Modeling, Simulation and Analysis",isOpenForSubmission:!1,hash:"b9db6d2645ef248ceb1b33ea75f38e88",slug:"satellite-systems-design-modeling-simulation-and-analysis",bookSignature:"Tien Nguyen",coverURL:"https://cdn.intechopen.com/books/images_new/7030.jpg",editors:[{id:"210657",title:"Dr.",name:"Tien M.",middleName:"Manh",surname:"Nguyen",slug:"tien-m.-nguyen",fullName:"Tien M. Nguyen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8472",title:"Bioactive Compounds in Nutraceutical and Functional Food for Good Human Health",subtitle:null,isOpenForSubmission:!1,hash:"8855452919b8495810ef8e88641feb20",slug:"bioactive-compounds-in-nutraceutical-and-functional-food-for-good-human-health",bookSignature:"Kavita Sharma, Kanchan Mishra, Kula Kamal Senapati and Corina Danciu",coverURL:"https://cdn.intechopen.com/books/images_new/8472.jpg",editors:[{id:"197731",title:"Dr.",name:"Kavita",middleName:null,surname:"Sharma",slug:"kavita-sharma",fullName:"Kavita Sharma"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10201",title:"Post-Transition Metals",subtitle:null,isOpenForSubmission:!1,hash:"cc7f53ff5269916e3ce29f65a51a87ae",slug:"post-transition-metals",bookSignature:"Mohammed Muzibur Rahman, Abdullah Mohammed Asiri, Anish Khan, Inamuddin and Thamer Tabbakh",coverURL:"https://cdn.intechopen.com/books/images_new/10201.jpg",editors:[{id:"24438",title:"Prof.",name:"Mohammed Muzibur",middleName:null,surname:"Rahman",slug:"mohammed-muzibur-rahman",fullName:"Mohammed Muzibur Rahman"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10413",title:"A Collection of Papers on Chaos Theory and Its Applications",subtitle:null,isOpenForSubmission:!1,hash:"900b71b164948830fec3d6254b7881f7",slug:"a-collection-of-papers-on-chaos-theory-and-its-applications",bookSignature:"Paul Bracken and Dimo I. Uzunov",coverURL:"https://cdn.intechopen.com/books/images_new/10413.jpg",editors:[{id:"92883",title:"Prof.",name:"Paul",middleName:null,surname:"Bracken",slug:"paul-bracken",fullName:"Paul Bracken"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9515",title:"Update in Geriatrics",subtitle:null,isOpenForSubmission:!1,hash:"913e16c0ae977474b283bbd4269564c8",slug:"update-in-geriatrics",bookSignature:"Somchai Amornyotin",coverURL:"https://cdn.intechopen.com/books/images_new/9515.jpg",editors:[{id:"185484",title:"Prof.",name:"Somchai",middleName:null,surname:"Amornyotin",slug:"somchai-amornyotin",fullName:"Somchai Amornyotin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"9559",title:"Teamwork in Healthcare",subtitle:null,isOpenForSubmission:!1,hash:"0053c2ff8d9ec4cc4aab82acea46a41e",slug:"teamwork-in-healthcare",bookSignature:"Michael S. Firstenberg and Stanislaw P. Stawicki",coverURL:"https://cdn.intechopen.com/books/images_new/9559.jpg",editedByType:"Edited by",editors:[{id:"64343",title:null,name:"Michael S.",middleName:null,surname:"Firstenberg",slug:"michael-s.-firstenberg",fullName:"Michael S. Firstenberg"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7016",title:"Cardiovascular Risk Factors in Pathology",subtitle:null,isOpenForSubmission:!1,hash:"7937d2c640c7515de372282c72ee5635",slug:"cardiovascular-risk-factors-in-pathology",bookSignature:"Alaeddin Abukabda, Maria Suciu and Minodora Andor",coverURL:"https://cdn.intechopen.com/books/images_new/7016.jpg",editedByType:"Edited by",editors:[{id:"307873",title:"Ph.D.",name:"Alaeddin",middleName:null,surname:"Abukabda",slug:"alaeddin-abukabda",fullName:"Alaeddin Abukabda"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9873",title:"Strategies of Sustainable Solid Waste Management",subtitle:null,isOpenForSubmission:!1,hash:"59b5ceeeedaf7449a30629923569388c",slug:"strategies-of-sustainable-solid-waste-management",bookSignature:"Hosam M. Saleh",coverURL:"https://cdn.intechopen.com/books/images_new/9873.jpg",editedByType:"Edited by",editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:"M.",surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9893",title:"Automation and Control",subtitle:null,isOpenForSubmission:!1,hash:"09ba24f6ac88af7f0aaff3029714ae48",slug:"automation-and-control",bookSignature:"Constantin Voloşencu, Serdar Küçük, José Guerrero and Oscar Valero",coverURL:"https://cdn.intechopen.com/books/images_new/9893.jpg",editedByType:"Edited by",editors:[{id:"1063",title:"Prof.",name:"Constantin",middleName:null,surname:"Volosencu",slug:"constantin-volosencu",fullName:"Constantin Volosencu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10405",title:"River Basin Management",subtitle:"Sustainability Issues and Planning Strategies",isOpenForSubmission:!1,hash:"5e5ddd0f2eda107ce19c4c06a55a8351",slug:"river-basin-management-sustainability-issues-and-planning-strategies",bookSignature:"José Simão Antunes Do Carmo",coverURL:"https://cdn.intechopen.com/books/images_new/10405.jpg",editedByType:"Edited by",editors:[{id:"67904",title:"Prof.",name:"José Simão",middleName:null,surname:"Antunes Do Carmo",slug:"jose-simao-antunes-do-carmo",fullName:"José Simão Antunes Do Carmo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9515",title:"Update in Geriatrics",subtitle:null,isOpenForSubmission:!1,hash:"913e16c0ae977474b283bbd4269564c8",slug:"update-in-geriatrics",bookSignature:"Somchai Amornyotin",coverURL:"https://cdn.intechopen.com/books/images_new/9515.jpg",editedByType:"Edited by",editors:[{id:"185484",title:"Prof.",name:"Somchai",middleName:null,surname:"Amornyotin",slug:"somchai-amornyotin",fullName:"Somchai Amornyotin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9021",title:"Novel Perspectives of Stem Cell Manufacturing and Therapies",subtitle:null,isOpenForSubmission:!1,hash:"522c6db871783d2a11c17b83f1fd4e18",slug:"novel-perspectives-of-stem-cell-manufacturing-and-therapies",bookSignature:"Diana Kitala and Ana Colette Maurício",coverURL:"https://cdn.intechopen.com/books/images_new/9021.jpg",editedByType:"Edited by",editors:[{id:"203598",title:"Ph.D.",name:"Diana",middleName:null,surname:"Kitala",slug:"diana-kitala",fullName:"Diana Kitala"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7030",title:"Satellite Systems",subtitle:"Design, Modeling, Simulation and Analysis",isOpenForSubmission:!1,hash:"b9db6d2645ef248ceb1b33ea75f38e88",slug:"satellite-systems-design-modeling-simulation-and-analysis",bookSignature:"Tien Nguyen",coverURL:"https://cdn.intechopen.com/books/images_new/7030.jpg",editedByType:"Edited by",editors:[{id:"210657",title:"Dr.",name:"Tien M.",middleName:"Manh",surname:"Nguyen",slug:"tien-m.-nguyen",fullName:"Tien M. Nguyen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10413",title:"A Collection of Papers on Chaos Theory and Its Applications",subtitle:null,isOpenForSubmission:!1,hash:"900b71b164948830fec3d6254b7881f7",slug:"a-collection-of-papers-on-chaos-theory-and-its-applications",bookSignature:"Paul Bracken and Dimo I. Uzunov",coverURL:"https://cdn.intechopen.com/books/images_new/10413.jpg",editedByType:"Edited by",editors:[{id:"92883",title:"Prof.",name:"Paul",middleName:null,surname:"Bracken",slug:"paul-bracken",fullName:"Paul Bracken"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9154",title:"Spinal Deformities in Adolescents, Adults and Older Adults",subtitle:null,isOpenForSubmission:!1,hash:"313f1dffa803b60a14ff1e6966e93d91",slug:"spinal-deformities-in-adolescents-adults-and-older-adults",bookSignature:"Josette Bettany-Saltikov and Gokulakannan Kandasamy",coverURL:"https://cdn.intechopen.com/books/images_new/9154.jpg",editedByType:"Edited by",editors:[{id:"94802",title:"Dr.",name:"Josette",middleName:null,surname:"Bettany-Saltikov",slug:"josette-bettany-saltikov",fullName:"Josette Bettany-Saltikov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"1093",title:"Thoracic Oncology",slug:"thoracic-oncology",parent:{title:"Oncology",slug:"medicine-oncology"},numberOfBooks:8,numberOfAuthorsAndEditors:201,numberOfWosCitations:35,numberOfCrossrefCitations:23,numberOfDimensionsCitations:46,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicSlug:"thoracic-oncology",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"10130",title:"Mesothelioma",subtitle:null,isOpenForSubmission:!1,hash:"6a0b7726fd9f57a0bf9583a81dfed0e3",slug:"mesothelioma",bookSignature:"Sonia Maciá",coverURL:"https://cdn.intechopen.com/books/images_new/10130.jpg",editedByType:"Edited by",editors:[{id:"281982",title:"Dr.",name:"Sonia",middleName:null,surname:"Maciá",slug:"sonia-macia",fullName:"Sonia Maciá"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9102",title:"Asbestos-related Diseases",subtitle:null,isOpenForSubmission:!1,hash:"05268073ee2a653571449e4519749085",slug:"asbestos-related-diseases",bookSignature:"Takemi Otsuki",coverURL:"https://cdn.intechopen.com/books/images_new/9102.jpg",editedByType:"Edited by",editors:[{id:"34101",title:"Prof.",name:"Takemi",middleName:null,surname:"Otsuki",slug:"takemi-otsuki",fullName:"Takemi Otsuki"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7091",title:"Esophageal Cancer and Beyond",subtitle:null,isOpenForSubmission:!1,hash:"4ecda741df661e21f77858de31105346",slug:"esophageal-cancer-and-beyond",bookSignature:"Jianyuan Chai",coverURL:"https://cdn.intechopen.com/books/images_new/7091.jpg",editedByType:"Edited by",editors:[{id:"28281",title:"Dr.",name:"Jianyuan",middleName:null,surname:"Chai",slug:"jianyuan-chai",fullName:"Jianyuan Chai"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6676",title:"Lung Cancer",subtitle:"Strategies for Diagnosis and Treatment",isOpenForSubmission:!1,hash:"b42744d3e884f96093849d9af11933f2",slug:"lung-cancer-strategies-for-diagnosis-and-treatment",bookSignature:"Alba Fabiola Costa Torres",coverURL:"https://cdn.intechopen.com/books/images_new/6676.jpg",editedByType:"Edited by",editors:[{id:"162855",title:"Dr.",name:"Alba Fabiola",middleName:null,surname:"Costa Torres",slug:"alba-fabiola-costa-torres",fullName:"Alba Fabiola Costa Torres"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5278",title:"Thyroid Cancer",subtitle:"Advances in Diagnosis and Therapy",isOpenForSubmission:!1,hash:"f845f2f12f985ef83aad2dde3bfc5161",slug:"thyroid-cancer-advances-in-diagnosis-and-therapy",bookSignature:"Hojjat Ahmadzadehfar",coverURL:"https://cdn.intechopen.com/books/images_new/5278.jpg",editedByType:"Edited by",editors:[{id:"80495",title:"Prof.",name:"Hojjat",middleName:null,surname:"Ahmadzadehfar; Md, MSc",slug:"hojjat-ahmadzadehfar-md-msc",fullName:"Hojjat Ahmadzadehfar; Md, MSc"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1168",title:"Malignant Mesothelioma",subtitle:null,isOpenForSubmission:!1,hash:"9d0120821f2ff7e1885baf8c71540b11",slug:"malignant-mesothelioma",bookSignature:"Carmen Belli and Santosh Anand",coverURL:"https://cdn.intechopen.com/books/images_new/1168.jpg",editedByType:"Edited by",editors:[{id:"101488",title:"Dr.",name:"Carmen",middleName:null,surname:"Belli",slug:"carmen-belli",fullName:"Carmen Belli"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"687",title:"Esophageal Cancer",subtitle:"Cell and Molecular Biology, Biomarkers, Nutrition and Treatment",isOpenForSubmission:!1,hash:"032d68a8b53825af052d4b8783d27aaa",slug:"esophageal-cancer-cell-and-molecular-biology-biomarkers-nutrition-and-treatment",bookSignature:"Ferdous Rastgar Jazii",coverURL:"https://cdn.intechopen.com/books/images_new/687.jpg",editedByType:"Edited by",editors:[{id:"82029",title:"Dr.",name:"Ferdous",middleName:null,surname:"Rastgar Jazii",slug:"ferdous-rastgar-jazii",fullName:"Ferdous Rastgar Jazii"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"974",title:"Mesotheliomas",subtitle:"Synonyms and Definition, Epidemiology, Etiology, Pathogenesis, Cyto-Histopathological Features, Clinic, Diagnosis, Treatment, Prognosis",isOpenForSubmission:!1,hash:"75d66c9a37715a7b43ddaf0ea3e46a63",slug:"mesotheliomas-synonyms-and-definition-epidemiology-etiology-pathogenesis-cyto-histopathological-features-clinic-diagnosis-treatment-prognosis",bookSignature:"Alexander Zubritsky",coverURL:"https://cdn.intechopen.com/books/images_new/974.jpg",editedByType:"Edited by",editors:[{id:"84298",title:"Dr",name:"Alexander",middleName:"N",surname:"Zubritsky",slug:"alexander-zubritsky",fullName:"Alexander Zubritsky"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:8,mostCitedChapters:[{id:"41536",doi:"10.5772/33138",title:"Effect of Asbestos on Anti-Tumor Immunity and Immunological Alteration in Patients with Malignant Mesothelioma",slug:"effect-of-asbestos-on-anti-tumor-immunity-and-immunological-alteration-in-patients-with-malignant-me",totalDownloads:1286,totalCrossrefCites:3,totalDimensionsCites:5,book:{slug:"malignant-mesothelioma",title:"Malignant Mesothelioma",fullTitle:"Malignant Mesothelioma"},signatures:"Yasumitsu Nishimura, Megumi Maeda, Naoko Kumagai-Takei, Hidenori Matsuzaki, Suni Lee, Kazuya Fukuoka, Takashi Nakano, Takumi Kishimoto and Takemi Otsuki",authors:[{id:"34101",title:"Prof.",name:"Takemi",middleName:null,surname:"Otsuki",slug:"takemi-otsuki",fullName:"Takemi Otsuki"},{id:"48627",title:"Dr.",name:"Naoko",middleName:null,surname:"Kumagai-Takei",slug:"naoko-kumagai-takei",fullName:"Naoko Kumagai-Takei"},{id:"48630",title:"Dr.",name:"Yoshie",middleName:null,surname:"Miura",slug:"yoshie-miura",fullName:"Yoshie Miura"},{id:"48631",title:"Dr.",name:"Yasumitsu",middleName:null,surname:"Nishimura",slug:"yasumitsu-nishimura",fullName:"Yasumitsu Nishimura"},{id:"104888",title:"Dr.",name:"Megumi",middleName:null,surname:"Maeda",slug:"megumi-maeda",fullName:"Megumi Maeda"},{id:"104893",title:"Dr.",name:"Suni",middleName:null,surname:"Lee",slug:"suni-lee",fullName:"Suni Lee"},{id:"104894",title:"Dr.",name:"Hidenori",middleName:null,surname:"Matsuzaki",slug:"hidenori-matsuzaki",fullName:"Hidenori Matsuzaki"},{id:"104897",title:"Associate Prof.",name:"Kazuya",middleName:null,surname:"Fukuoka",slug:"kazuya-fukuoka",fullName:"Kazuya Fukuoka"},{id:"104898",title:"Prof.",name:"Takashi",middleName:null,surname:"Nakano",slug:"takashi-nakano",fullName:"Takashi Nakano"},{id:"104902",title:"Dr.",name:"Takumi",middleName:null,surname:"Kishimoto",slug:"takumi-kishimoto",fullName:"Takumi Kishimoto"}]},{id:"51576",doi:"10.5772/64374",title:"Elastography: A New Ultrasound Technique in Nodular Thyroid Pathology",slug:"elastography-a-new-ultrasound-technique-in-nodular-thyroid-pathology",totalDownloads:1693,totalCrossrefCites:2,totalDimensionsCites:4,book:{slug:"thyroid-cancer-advances-in-diagnosis-and-therapy",title:"Thyroid Cancer",fullTitle:"Thyroid Cancer - Advances in Diagnosis and Therapy"},signatures:"Dana Stoian, Timar Bogdan, Marius Craina, Mihaela Craciunescu,\nRomulus Timar and Adalbert Schiller",authors:[{id:"105871",title:"Dr.",name:"Romulus",middleName:null,surname:"Timar",slug:"romulus-timar",fullName:"Romulus Timar"},{id:"182103",title:"Dr.",name:"Dana",middleName:"I",surname:"Stoian",slug:"dana-stoian",fullName:"Dana Stoian"},{id:"182104",title:"Prof.",name:"Marius",middleName:null,surname:"Craina",slug:"marius-craina",fullName:"Marius Craina"},{id:"182105",title:"Dr.",name:"Bogdan",middleName:null,surname:"Timar",slug:"bogdan-timar",fullName:"Bogdan Timar"},{id:"182245",title:"Dr.",name:"Mihaela",middleName:null,surname:"Craciunescu",slug:"mihaela-craciunescu",fullName:"Mihaela Craciunescu"},{id:"183185",title:"Prof.",name:"Adalbert",middleName:null,surname:"Schiller",slug:"adalbert-schiller",fullName:"Adalbert Schiller"}]},{id:"51836",doi:"10.5772/64609",title:"Dr. Saul Hertz (1905–1950) Discovers the Medical Uses of Radioactive Iodine: The First Targeted Cancer Therapy",slug:"dr-saul-hertz-1905-1950-discovers-the-medical-uses-of-radioactive-iodine-the-first-targeted-cancer-t",totalDownloads:1330,totalCrossrefCites:3,totalDimensionsCites:4,book:{slug:"thyroid-cancer-advances-in-diagnosis-and-therapy",title:"Thyroid Cancer",fullTitle:"Thyroid Cancer - Advances in Diagnosis and Therapy"},signatures:"Barbara Hertz",authors:[{id:"184018",title:"Dr.",name:"Barbara",middleName:null,surname:"Hertz",slug:"barbara-hertz",fullName:"Barbara Hertz"}]}],mostDownloadedChaptersLast30Days:[{id:"61811",title:"The Clinical Relevance of Gastroesophageal Reflux Disease and Laryngopharyngeal Reflux in Clinical Practice",slug:"the-clinical-relevance-of-gastroesophageal-reflux-disease-and-laryngopharyngeal-reflux-in-clinical-p",totalDownloads:693,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"esophageal-cancer-and-beyond",title:"Esophageal Cancer and Beyond",fullTitle:"Esophageal Cancer and Beyond"},signatures:"Aragona Salvatore Emanuele, Mereghetti Giada and Giorgio\nCiprandi",authors:[{id:"247667",title:"Prof.",name:"Emanuele Salvatore",middleName:null,surname:"Aragona",slug:"emanuele-salvatore-aragona",fullName:"Emanuele Salvatore Aragona"}]},{id:"61934",title:"The Role of Esophagus in Voice Rehabilitation of Laryngectomees",slug:"the-role-of-esophagus-in-voice-rehabilitation-of-laryngectomees",totalDownloads:629,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"esophageal-cancer-and-beyond",title:"Esophageal Cancer and Beyond",fullTitle:"Esophageal Cancer and Beyond"},signatures:"Ljiljana Širić, Marinela Rosso and Aleksandar Včev",authors:[{id:"249257",title:"Dr.",name:"Ljiljana",middleName:null,surname:"Širić",slug:"ljiljana-siric",fullName:"Ljiljana Širić"},{id:"249659",title:"Dr.",name:"Marinela",middleName:null,surname:"Rosso",slug:"marinela-rosso",fullName:"Marinela Rosso"}]},{id:"62305",title:"Pleural Effusions in Lung Cancer: Detection and Treatment",slug:"pleural-effusions-in-lung-cancer-detection-and-treatment",totalDownloads:700,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"lung-cancer-strategies-for-diagnosis-and-treatment",title:"Lung Cancer",fullTitle:"Lung Cancer - Strategies for Diagnosis and Treatment"},signatures:"Milic Medenica, Miras Medenica and Danilo Cosovic",authors:[{id:"246939",title:"Prof.",name:"Milic",middleName:null,surname:"Medenica",slug:"milic-medenica",fullName:"Milic Medenica"},{id:"247717",title:"Dr.",name:"Miras",middleName:null,surname:"Medenica",slug:"miras-medenica",fullName:"Miras Medenica"},{id:"253456",title:"Dr.",name:"Danilo",middleName:null,surname:"Cosovic",slug:"danilo-cosovic",fullName:"Danilo Cosovic"}]},{id:"51929",title:"Management of Rare Thyroid Malignancies",slug:"management-of-rare-thyroid-malignancies",totalDownloads:838,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"thyroid-cancer-advances-in-diagnosis-and-therapy",title:"Thyroid Cancer",fullTitle:"Thyroid Cancer - Advances in Diagnosis and Therapy"},signatures:"Moustafa Mourad, David Chan, Sameep Kadakia and Yadranko\nDucic",authors:[{id:"183645",title:"Dr.",name:"Yadranko",middleName:null,surname:"Ducic",slug:"yadranko-ducic",fullName:"Yadranko Ducic"}]},{id:"70769",title:"Suppressed Immune System Caused by Exposure to Asbestos and Malignant Mesothelioma",slug:"suppressed-immune-system-caused-by-exposure-to-asbestos-and-malignant-mesothelioma",totalDownloads:303,totalCrossrefCites:1,totalDimensionsCites:1,book:{slug:"asbestos-related-diseases",title:"Asbestos-related Diseases",fullTitle:"Asbestos-related Diseases"},signatures:"Yasumitsu Nishimura, Naoko Kumagai-Takei, Suni Lee, Kei Yoshitome and Takemi Otsuki",authors:[{id:"34101",title:"Prof.",name:"Takemi",middleName:null,surname:"Otsuki",slug:"takemi-otsuki",fullName:"Takemi Otsuki"},{id:"48627",title:"Dr.",name:"Naoko",middleName:null,surname:"Kumagai-Takei",slug:"naoko-kumagai-takei",fullName:"Naoko Kumagai-Takei"},{id:"48631",title:"Dr.",name:"Yasumitsu",middleName:null,surname:"Nishimura",slug:"yasumitsu-nishimura",fullName:"Yasumitsu Nishimura"},{id:"104893",title:"Dr.",name:"Suni",middleName:null,surname:"Lee",slug:"suni-lee",fullName:"Suni Lee"},{id:"219725",title:"Dr.",name:"Kei",middleName:null,surname:"Yoshitome",slug:"kei-yoshitome",fullName:"Kei Yoshitome"}]},{id:"62225",title:"Prevention and Management of Complications from Esophagectomy",slug:"prevention-and-management-of-complications-from-esophagectomy",totalDownloads:887,totalCrossrefCites:1,totalDimensionsCites:3,book:{slug:"esophageal-cancer-and-beyond",title:"Esophageal Cancer and Beyond",fullTitle:"Esophageal Cancer and Beyond"},signatures:"Jacqueline Oxenberg",authors:[{id:"246492",title:"Dr.",name:"Jacqueline",middleName:null,surname:"Oxenberg",slug:"jacqueline-oxenberg",fullName:"Jacqueline Oxenberg"}]},{id:"61995",title:"Targeted Photodynamic Therapy for Improved Lung Cancer Treatment",slug:"targeted-photodynamic-therapy-for-improved-lung-cancer-treatment",totalDownloads:596,totalCrossrefCites:0,totalDimensionsCites:1,book:{slug:"lung-cancer-strategies-for-diagnosis-and-treatment",title:"Lung Cancer",fullTitle:"Lung Cancer - Strategies for Diagnosis and Treatment"},signatures:"Anine Crous and Heidi Abrahamse",authors:[{id:"60947",title:"Prof.",name:"Heidi",middleName:null,surname:"Abrahamse",slug:"heidi-abrahamse",fullName:"Heidi Abrahamse"},{id:"244468",title:"Ms.",name:"Anine",middleName:null,surname:"Crous",slug:"anine-crous",fullName:"Anine Crous"}]},{id:"62239",title:"Chemoresistance of Lung Cancer Cells: 2D and 3D In Vitro Models for Anticancer Drug Screening",slug:"chemoresistance-of-lung-cancer-cells-2d-and-3d-in-vitro-models-for-anticancer-drug-screening",totalDownloads:700,totalCrossrefCites:2,totalDimensionsCites:1,book:{slug:"lung-cancer-strategies-for-diagnosis-and-treatment",title:"Lung Cancer",fullTitle:"Lung Cancer - Strategies for Diagnosis and Treatment"},signatures:"Vivek Kaushik, Juan Sebastian Yakisich, Yogesh Kulkarni, Neelam\nAzad and Anand Krishnan V. Iyer",authors:[{id:"245497",title:"Dr.",name:"Juan",middleName:"Sebastian",surname:"Yakisich",slug:"juan-yakisich",fullName:"Juan Yakisich"},{id:"245499",title:"Dr.",name:"Vivek",middleName:null,surname:"Kaushik",slug:"vivek-kaushik",fullName:"Vivek Kaushik"},{id:"245502",title:"Dr.",name:"Yogesh",middleName:null,surname:"Kulkarni",slug:"yogesh-kulkarni",fullName:"Yogesh Kulkarni"},{id:"245503",title:"Dr.",name:"Neelam",middleName:null,surname:"Azad",slug:"neelam-azad",fullName:"Neelam Azad"},{id:"245505",title:"Dr.",name:"Anand",middleName:null,surname:"Iyer",slug:"anand-iyer",fullName:"Anand Iyer"}]},{id:"61716",title:"Introductory Chapter: Esophagus and Esophageal Cancer",slug:"introductory-chapter-esophagus-and-esophageal-cancer",totalDownloads:445,totalCrossrefCites:0,totalDimensionsCites:1,book:{slug:"esophageal-cancer-and-beyond",title:"Esophageal Cancer and Beyond",fullTitle:"Esophageal Cancer and Beyond"},signatures:"Jianyuan Chai",authors:[{id:"28281",title:"Dr.",name:"Jianyuan",middleName:null,surname:"Chai",slug:"jianyuan-chai",fullName:"Jianyuan Chai"}]},{id:"51574",title:"Thyroid Cancer in Children and Adolescents",slug:"thyroid-cancer-in-children-and-adolescents",totalDownloads:1108,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"thyroid-cancer-advances-in-diagnosis-and-therapy",title:"Thyroid Cancer",fullTitle:"Thyroid Cancer - Advances in Diagnosis and Therapy"},signatures:"Eman Marie, Mahnaz Kousha and Reza Vali",authors:[{id:"181725",title:"Dr.",name:"Reza",middleName:null,surname:"Vali",slug:"reza-vali",fullName:"Reza Vali"}]}],onlineFirstChaptersFilter:{topicSlug:"thoracic-oncology",limit:3,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[{type:"book",id:"10176",title:"Microgrids and Local Energy Systems",subtitle:null,isOpenForSubmission:!0,hash:"c32b4a5351a88f263074b0d0ca813a9c",slug:null,bookSignature:"Prof. Nick Jenkins",coverURL:"https://cdn.intechopen.com/books/images_new/10176.jpg",editedByType:null,editors:[{id:"55219",title:"Prof.",name:"Nick",middleName:null,surname:"Jenkins",slug:"nick-jenkins",fullName:"Nick Jenkins"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:8,limit:8,total:1},route:{name:"profile.detail",path:"/profiles/186016/martina-erken",hash:"",query:{},params:{id:"186016",slug:"martina-erken"},fullPath:"/profiles/186016/martina-erken",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()